<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US5550156 - Blending docosahexaenoic acid containing microbial oil, a gamma linolenic ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Blending docosahexaenoic acid containing microbial oil, a gamma linolenic acid containing oil, adding to infant formula"><meta name="DC.contributor" content="David J. Kyle" scheme="inventor"><meta name="DC.contributor" content="Martek Corporation" scheme="assignee"><meta name="DC.date" content="1994-12-19" scheme="dateSubmitted"><meta name="DC.description" content="The present invention relates to compositions including blends of microbial oils, methods of using such compositions, particularly as supplements for infant formula, and methods of increasing the amount of long chain polyunsaturated fatty acids in infant formula."><meta name="DC.date" content="1996-8-27" scheme="issued"><meta name="DC.relation" content="EP:0140805" scheme="references"><meta name="DC.relation" content="EP:0148303:A1" scheme="references"><meta name="DC.relation" content="EP:0223960:A2" scheme="references"><meta name="DC.relation" content="EP:0231904:A2" scheme="references"><meta name="DC.relation" content="EP:0269351:A2" scheme="references"><meta name="DC.relation" content="EP:0276982:A2" scheme="references"><meta name="DC.relation" content="EP:0296751:A1" scheme="references"><meta name="DC.relation" content="JP:H01132371" scheme="references"><meta name="DC.relation" content="JP:H01196255" scheme="references"><meta name="DC.relation" content="JP:H01215245" scheme="references"><meta name="DC.relation" content="JP:H01304892" scheme="references"><meta name="DC.relation" content="JP:S6438007" scheme="references"><meta name="DC.relation" content="JP:S6480250" scheme="references"><meta name="DC.relation" content="US:2611706" scheme="references"><meta name="DC.relation" content="US:2923628" scheme="references"><meta name="DC.relation" content="US:3458625" scheme="references"><meta name="DC.relation" content="US:3542560" scheme="references"><meta name="DC.relation" content="US:3649295" scheme="references"><meta name="DC.relation" content="US:4058594" scheme="references"><meta name="DC.relation" content="US:4216236" scheme="references"><meta name="DC.relation" content="US:4282265" scheme="references"><meta name="DC.relation" content="US:4303692" scheme="references"><meta name="DC.relation" content="US:4513008" scheme="references"><meta name="DC.relation" content="US:4526793" scheme="references"><meta name="DC.relation" content="US:4526902" scheme="references"><meta name="DC.relation" content="US:4544559" scheme="references"><meta name="DC.relation" content="US:4614663" scheme="references"><meta name="DC.relation" content="US:4670285" scheme="references"><meta name="DC.relation" content="US:4681896" scheme="references"><meta name="DC.relation" content="US:4752618" scheme="references"><meta name="DC.relation" content="US:4780456" scheme="references"><meta name="DC.relation" content="US:4792418" scheme="references"><meta name="DC.relation" content="US:4810497" scheme="references"><meta name="DC.relation" content="US:4820731" scheme="references"><meta name="DC.relation" content="US:4826877" scheme="references"><meta name="DC.relation" content="US:4843095" scheme="references"><meta name="DC.relation" content="US:4851343" scheme="references"><meta name="DC.relation" content="US:4868001" scheme="references"><meta name="DC.relation" content="US:4874603" scheme="references"><meta name="DC.relation" content="US:4874629" scheme="references"><meta name="DC.relation" content="US:4876107" scheme="references"><meta name="DC.relation" content="US:4911944" scheme="references"><meta name="DC.relation" content="US:4920098" scheme="references"><meta name="DC.relation" content="US:4938984" scheme="references"><meta name="DC.relation" content="US:4960795" scheme="references"><meta name="DC.relation" content="US:4963385" scheme="references"><meta name="DC.relation" content="US:5013569" scheme="references"><meta name="DC.relation" content="US:5116871" scheme="references"><meta name="DC.relation" content="US:5120760" scheme="references"><meta name="DC.relation" content="US:5130242" scheme="references"><meta name="DC.relation" content="US:5198468" scheme="references"><meta name="DC.relation" content="US:5204250" scheme="references"><meta name="DC.relation" content="US:5234702" scheme="references"><meta name="DC.relation" content="US:5338673" scheme="references"><meta name="DC.relation" content="US:5397591" scheme="references"><meta name="DC.relation" content="US:5407957" scheme="references"><meta name="DC.relation" content="WO:1989000606:A1" scheme="references"><meta name="DC.relation" content="WO:1990004391:A1" scheme="references"><meta name="DC.relation" content="WO:1990013656:A1" scheme="references"><meta name="DC.relation" content="WO:1992013086:A1" scheme="references"><meta name="citation_reference" content="Aaronson, et al., 1980, Microalgae as a Source of Chemicals and Natural Products, in Algal Biomass, Shelef, et al., eds., Elsevier, pp. 575 601."><meta name="citation_reference" content="Aaronson, et al., 1980,&quot;Microalgae as a Source of Chemicals and Natural Products,&quot; in Algal Biomass, Shelef, et al., eds., Elsevier, pp. 575-601."><meta name="citation_reference" content="Ackman, R.G., 1989, &quot;Problems in Fish Oils and Concentrates,&quot; in Fats for the Future, Chap. 13, pp. 189-200, Cambie, ed."><meta name="citation_reference" content="Ackman, R.G., 1989, Problems in Fish Oils and Concentrates, in Fats for the Future, Chap. 13, pp. 189 200, Cambie, ed."><meta name="citation_reference" content="Beach, et al., 1973, &quot;Environmental Influences on the Docosahexaenoiate Content of the Triacylglycerols and Phosphatidylcholine of a Heterotrophic, Marine Dinoflagellate, Crypthecodinium cohnii,&quot; Biochim. Biophys. Acta, 316:56-65."><meta name="citation_reference" content="Beach, et al., 1973, Environmental Influences on the Docosahexaenoiate Content of the Triacylglycerols and Phosphatidylcholine of a Heterotrophic, Marine Dinoflagellate, Crypthecodinium cohnii, Biochim. Biophys. Acta, 316:56 65."><meta name="citation_reference" content="Bitman, et al., 1983, &quot;Comparison of the Lipid Composition of Breast Milk from Mothers of Term and Preterm Infants,&quot; Amer. J. Clin. Nutr., 38:300-312."><meta name="citation_reference" content="Bitman, et al., 1983, Comparison of the Lipid Composition of Breast Milk from Mothers of Term and Preterm Infants, Amer. J. Clin. Nutr., 38:300 312."><meta name="citation_reference" content="Bourre, et al., 1990, &quot;Desaturase in Brain and Liver During Development and Aging,&quot; Lipids, 25:354-356."><meta name="citation_reference" content="Bourre, et al., 1990, Desaturase in Brain and Liver During Development and Aging, Lipids, 25:354 356."><meta name="citation_reference" content="Bracco, et al., 1978, &quot;Human Milk Lipids and Problems Related To Their Replacement,&quot; extract from Annales Nestle, No. 40, 55-81."><meta name="citation_reference" content="Bracco, et al., 1978, Human Milk Lipids and Problems Related To Their Replacement, extract from Annales Nestle , No. 40, 55 81."><meta name="citation_reference" content="Carlson, 1987, &quot;Effect of Fish Oil Supplementation on the n-3 Fatty Acid Content of Red Blood Cell Membranes in Preterm Infants,&quot; Pediatri, Res., 21:507-510."><meta name="citation_reference" content="Carlson, 1987, Effect of Fish Oil Supplementation on the n 3 Fatty Acid Content of Red Blood Cell Membranes in Preterm Infants, Pediatri, Res., 21:507 510."><meta name="citation_reference" content="Carlson, et al., 1990, &quot;Growth and Development of Very Low-Birthweight Infants in Relation to n-3 and n-6 Essential Fatty Acid Status,&quot; Inform, 1:192-196 (Essential Fatty Acids and Eicosanoids--Invited Papers from the Third International Congress, American Oil Chemists&#39; Society, Champaign, Ill."><meta name="citation_reference" content="Carlson, et al., 1990, Growth and Development of Very Low Birthweight Infants in Relation to n 3 and n 6 Essential Fatty Acid Status, Inform, 1:192 196 (Essential Fatty Acids and Eicosanoids Invited Papers from the Third International Congress, American Oil Chemists Society, Champaign, Ill."><meta name="citation_reference" content="Carlson, et al., 1992, Essential Fatty Acids and Eicosenoids, Sinclair, et al., eds., American Oil Chem. Society, Champaign, Illinois."><meta name="citation_reference" content="Clandinin, et al., 1985, &quot;Long Chain Fatty Acids in Human Milk: Are They of Benefit to the Newborn?&quot; in Composition and Physiological Properties of Human Milk, Proc. of the Internat&#39;l. Workshop on the Composition of Physiological Properties of Human Milk, Kiel, Germany, Schaub, J., ed."><meta name="citation_reference" content="Clandinin, et al., 1985, Long Chain Fatty Acids in Human Milk: Are They of Benefit to the Newborn in Composition and Physiological Properties of Human Milk, Proc. of the Internat l. Workshop on the Composition of Physiological Properties of Human Milk, Kiel, Germany, Schaub, J., ed."><meta name="citation_reference" content="Hansson, et al., 1988, &quot;Effect of Culture Conditions on Mycelial Growth and Production of gamma (?)-Linolenic Acid by the Fungus Mortierella ramanniana,&quot; Appl. Microbiol. Biotechnol., 28:240-246."><meta name="citation_reference" content="Hansson, et al., 1988, Effect of Culture Conditions on Mycelial Growth and Production of gamma ( ) Linolenic Acid by the Fungus Mortierella ramanniana, Appl. Microbiol. Biotechnol., 28:240 246."><meta name="citation_reference" content="Harrington, et al., &quot;The Polyunsaturated Fatty Acids of Marine Dinoflagellates,&quot; J. Protozool., 17:213-219, 1970."><meta name="citation_reference" content="Harrington, et al., The Polyunsaturated Fatty Acids of Marine Dinoflagellates, J. Protozool., 17:213 219, 1970."><meta name="citation_reference" content="Harzer, et al., 1983, &quot;Changing Patterns of Human Milk Lipids in the Course of the Lactation and During the Day,&quot; Am. J. Clin. Nutr., 37:612-621."><meta name="citation_reference" content="Harzer, et al., 1983, Changing Patterns of Human Milk Lipids in the Course of the Lactation and During the Day, Am. J. Clin. Nutr., 37:612 621."><meta name="citation_reference" content="Henderson, et al., &quot;Lipid Compostion and Biosynthesis in the Marine Dinoflagellate Crypthecodinium cohnii,&quot; Phytochem., 27:1679-1683 (1988)."><meta name="citation_reference" content="Henderson, et al., Lipid Compostion and Biosynthesis in the Marine Dinoflagellate Crypthecodinium cohnii, Phytochem., 27:1679 1683 (1988)."><meta name="citation_reference" content="Innis, et al. &quot;Plasma and Red Blood Cell Fatty Acids of Low-Birth-Weight Infants Fed Their Mother&#39;s Expressed Breast Milk or Preterm-Infant Formula,&quot; Am. J. of Clin. Nutri., 1990, 51:994-1000."><meta name="citation_reference" content="Innis, et al. Plasma and Red Blood Cell Fatty Acids of Low Birth Weight Infants Fed Their Mother s Expressed Breast Milk or Preterm Infant Formula, Am. J. of Clin. Nutri., 1990, 51:994 1000."><meta name="citation_reference" content="Kame, et al., 1984, &quot;Use of Fish Oil Fatty Acids (EPA and DHA) in Nutrition-Supplementing Foods and in Drugs,&quot; Chem. Abst., 100:6638d."><meta name="citation_reference" content="Kame, et al., 1984, Use of Fish Oil Fatty Acids (EPA and DHA) in Nutrition Supplementing Foods and in Drugs, Chem. Abst., 100:6638d."><meta name="citation_reference" content="Kyle, 1991, Adv. Applied Biotech., 12."><meta name="citation_reference" content="Pohl, et al., 1979, &quot;Fatty Acids and Lipids of Marine Algae and the Control of Their Biosynthesis by Environmental Factors,&quot; Marine Algae in Pharmaceutical Science, pp. 473-523."><meta name="citation_reference" content="Pohl, et al., 1979, Fatty Acids and Lipids of Marine Algae and the Control of Their Biosynthesis by Environmental Factors, Marine Algae in Pharmaceutical Science, pp. 473 523."><meta name="citation_reference" content="Puppione, et al., 1988, &quot;Marine Mammals&quot; Animal Models for Studying the Digestion and Transport of Dietary Fats Enriched in ω-3 Fatty Acids. Positional Analyses of Milk Fat Triacylglycerol Molecules, in Dietary ω-3 and ω-6 Fatty Acids, Galli, et al., eds., Plenum Press."><meta name="citation_reference" content="Puppione, et al., 1988, Marine Mammals Animal Models for Studying the Digestion and Transport of Dietary Fats Enriched in 3 Fatty Acids. Positional Analyses of Milk Fat Triacylglycerol Molecules, in Dietary 3 and 6 Fatty Acids, Galli, et al., eds., Plenum Press."><meta name="citation_reference" content="Ratledge, 1986, &quot;The Potential of Microorganisms for Oil Production--A Review of Recent Publications,&quot; Baldwin, et al., eds., Proc. World Conf. Emerging Technol. Fats Oils Industr., Am. Oil Chem Soc., pp. 318-330."><meta name="citation_reference" content="Ratledge, 1986, The Potential of Microorganisms for Oil Production A Review of Recent Publications, Baldwin, et al., eds., Proc. World Conf. Emerging Technol. Fats Oils Industr., Am. Oil Chem Soc., pp. 318 330."><meta name="citation_reference" content="Sanders, et al., 1978, &quot;Studies of Vegans: The Fatty Acid Composition of Plasma Choline Phosphoglycerides, Erythrocytes, Adipose Tissue, and Breast Milk, and some Indicators of Susceptibility to Ischemic Heart Disease in Vegans and Omnivore Controls,&quot; Am. J. Clin. Nutri., 31:805-813."><meta name="citation_reference" content="Sanders, et al., 1978, Studies of Vegans: The Fatty Acid Composition of Plasma Choline Phosphoglycerides, Erythrocytes, Adipose Tissue, and Breast Milk, and some Indicators of Susceptibility to Ischemic Heart Disease in Vegans and Omnivore Controls, Am. J. Clin. Nutri., 31:805 813."><meta name="citation_reference" content="Shifrin, 1984, &quot;Oils From Microalgae,&quot; in Biotechnology for the Oils and Fats Industry, Ratledge, et al., eds., American Oil Chemists Society, Champaign, IL, pp. 145-162."><meta name="citation_reference" content="Shifrin, 1984, Oils From Microalgae, in Biotechnology for the Oils and Fats Industry, Ratledge, et al., eds., American Oil Chemists Society, Champaign, IL, pp. 145 162."><meta name="citation_reference" content="Shifrin, et al., &quot;Phytoplankton Lipids: Environmental Influences on Production and Possible Commercial Applications,&quot; in Algal Biomass, Shelef, et al., eds., Elsevier, pp. 627-645 (1980)."><meta name="citation_reference" content="Shifrin, et al., Phytoplankton Lipids: Environmental Influences on Production and Possible Commercial Applications, in Algal Biomass, Shelef, et al., eds., Elsevier, pp. 627 645 (1980)."><meta name="citation_reference" content="Shimizu, et al. (1988), &quot;Production of C-20 Polyunsaturated Fatty Acids by Fungi,&quot; ISF-JOCS World Conference."><meta name="citation_reference" content="Shimizu, et al. (1988), &quot;Production of Eicosapentaenoic Acid by Mortierella Fungi,&quot; J. Am. Oil Chem. Soc., 65:1455."><meta name="citation_reference" content="Shimizu, et al. (1988), Production of C 20 Polyunsaturated Fatty Acids by Fungi, ISF JOCS World Conference."><meta name="citation_reference" content="Shimizu, et al. (1988), Production of Eicosapentaenoic Acid by Mortierella Fungi, J. Am. Oil Chem. Soc., 65:1455."><meta name="citation_reference" content="Shimizu, et al. (1989), &quot;Conversion of Linseed Oil to an Eicosapentaenoic Acid-Containing Oil by Mortierella alpina 1S-4 at Low Temperature,&quot; Appl. Microb. Biotechnol., 31:1(-4)."><meta name="citation_reference" content="Shimizu, et al. (1989), Conversion of Linseed Oil to an Eicosapentaenoic Acid Containing Oil by Mortierella alpina 1S 4 at Low Temperature, Appl. Microb. Biotechnol., 31:1( 4)."><meta name="citation_reference" content="Shinmen, et al. (1989), &quot;Production of Arachidonic Acid by Mortierella fungi,&quot; Appl. Microb. Biotech., 31:11-16."><meta name="citation_reference" content="Shinmen, et al. (1989), Production of Arachidonic Acid by Mortierella fungi, Appl. Microb. Biotech., 31:11 16."><meta name="citation_reference" content="Sonnenborn, et al., &quot;Purification and Properties of the Fatty Acid Synthetase Complex From the Marine Dinoflagellate, Crypthecodinium cohnii,&quot; Biochem. Biophys. Acta, 712:523-534 (1982)."><meta name="citation_reference" content="Sonnenborn, et al., Purification and Properties of the Fatty Acid Synthetase Complex From the Marine Dinoflagellate, Crypthecodinium cohnii, Biochem. Biophys. Acta, 712:523 534 (1982)."><meta name="citation_reference" content="Totani, et al. (1987), &quot;The Filamentous Fungus Mortierella alpina, High in Arachidonic Acid,&quot; Lipids, 22:1060."><meta name="citation_reference" content="Totani, et al. (1987), The Filamentous Fungus Mortierella alpina, High in Arachidonic Acid, Lipids, 22:1060."><meta name="citation_reference" content="Totani, et al. (1988), in &quot;Production of Arachidonic Acid by Mortirella alpina,&quot; ISF-JOCS World Conference."><meta name="citation_reference" content="Totani, et al. (1988), in Production of Arachidonic Acid by Mortirella alpina , ISF JOCS World Conference."><meta name="citation_reference" content="Weaver, et al., 1989, &quot;The Effect of Positional Placement of EPA in Ingested Triglyceride on EPA Accumulation in Human Platelet and Plasma Phospholipids,&quot; in Health Effects of Fish and Fish Oils, Clandra, ed., St. John&#39;s, Newfoundland."><meta name="citation_reference" content="Weaver, et al., 1989, The Effect of Positional Placement of EPA in Ingested Triglyceride on EPA Accumulation in Human Platelet and Plasma Phospholipids, in Health Effects of Fish and Fish Oils, Clandra, ed., St. John s, Newfoundland."><meta name="citation_reference" content="Yamada, et al. (1987), &quot;Production of Arachidonic Acid and Eicosapentaenoic Acid by Microorganisms,&quot; pp. 173-177, Proc. World Congr. Biotechnol. for Oils and Fats Industr., Applewhite, ed., Am. Oil Chem. Soc., p. 173."><meta name="citation_reference" content="Yamada, et al. (1987), Production of Arachidonic Acid and Eicosapentaenoic Acid by Microorganisms, pp. 173 177, Proc. World Congr. Biotechnol. for Oils and Fats Industr., Applewhite, ed., Am. Oil Chem. Soc., p. 173."><meta name="citation_reference" content="Yamada, et al. (1989), &quot;Biotechnological Processes for Production of Poly-Unsaturated Fatty Acids,&quot; J. Disp. Sci. &amp; Tech., 10:561-579."><meta name="citation_reference" content="Yamada, et al. (1989), Biotechnological Processes for Production of Poly Unsaturated Fatty Acids, J. Disp. Sci. &amp; Tech., 10:561 579."><meta name="citation_reference" content="Yeh, et al., 1990, &quot;Enrichment of (n-3) Fatty Acids of Suckling Rats by Maternal Dietary Menhaden Oil,&quot; J. Nutr., 120."><meta name="citation_reference" content="Yeh, et al., 1990, Enrichment of (n 3) Fatty Acids of Suckling Rats by Maternal Dietary Menhaden Oil, J. Nutr., 120."><meta name="citation_reference" content="Yongmanitchai, et al., &quot;Omega-3 Fatty Acids: Alternative Sources of Production,&quot; Process Biochem., 24:117-125 (1989)."><meta name="citation_reference" content="Yongmanitchai, et al., Omega 3 Fatty Acids: Alternative Sources of Production, Process Biochem., 24:117 125 (1989)."><meta name="citation_patent_number" content="US:5550156"><meta name="citation_patent_application_number" content="US:08/358,474"><link rel="canonical" href="http://www.google.com/patents/US5550156"/><meta property="og:url" content="http://www.google.com/patents/US5550156"/><meta name="title" content="Patent US5550156 - Blending docosahexaenoic acid containing microbial oil, a gamma linolenic acid containing oil, adding to infant formula"/><meta name="description" content="The present invention relates to compositions including blends of microbial oils, methods of using such compositions, particularly as supplements for infant formula, and methods of increasing the amount of long chain polyunsaturated fatty acids in infant formula."/><meta property="og:title" content="Patent US5550156 - Blending docosahexaenoic acid containing microbial oil, a gamma linolenic acid containing oil, adding to infant formula"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("mpvtU4nkAY2NogTGqYKYDg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("JPN"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("mpvtU4nkAY2NogTGqYKYDg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("JPN"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us5550156?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US5550156"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=yOI_BAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS5550156&amp;usg=AFQjCNGQqK4940prJJgkwKS5RL4bD7_cUw" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5550156.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US5550156.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US5550156" style="display:none"><span itemprop="description">The present invention relates to compositions including blends of microbial oils, methods of using such compositions, particularly as supplements for infant formula, and methods of increasing the amount of long chain polyunsaturated fatty acids in infant formula....</span><span itemprop="url">http://www.google.com/patents/US5550156?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US5550156 - Blending docosahexaenoic acid containing microbial oil, a gamma linolenic acid containing oil, adding to infant formula</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US5550156 - Blending docosahexaenoic acid containing microbial oil, a gamma linolenic acid containing oil, adding to infant formula" title="Patent US5550156 - Blending docosahexaenoic acid containing microbial oil, a gamma linolenic acid containing oil, adding to infant formula"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US5550156 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/358,474</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Aug 27, 1996</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Dec 19, 1994</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Jan 24, 1991</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2101274A1">CA2101274A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2101274C">CA2101274C</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE568606T1">DE568606T1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69231793D1">DE69231793D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69231793T2">DE69231793T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0568606A1">EP0568606A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0568606A4">EP0568606A4</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0568606B1">EP0568606B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1092352A2">EP1092352A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1092352A3">EP1092352A3</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1787532A2">EP1787532A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1787532A3">EP1787532A3</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1832181A2">EP1832181A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1832181A3">EP1832181A3</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1961312A2">EP1961312A2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1961312A3">EP1961312A3</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5374657">US5374657</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1992012711A1">WO1992012711A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08358474, </span><span class="patent-bibdata-value">358474, </span><span class="patent-bibdata-value">US 5550156 A, </span><span class="patent-bibdata-value">US 5550156A, </span><span class="patent-bibdata-value">US-A-5550156, </span><span class="patent-bibdata-value">US5550156 A, </span><span class="patent-bibdata-value">US5550156A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22David+J.+Kyle%22">David J. Kyle</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Martek+Corporation%22">Martek Corporation</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5550156.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5550156.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5550156.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (60),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (68),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (85),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (21),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (7)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/5550156&usg=AFQjCNEcFmZvLwTKSu1d6djYNchbdoye3A">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D5550156&usg=AFQjCNH4GJlYDDfW7eEPk0-I_SulyY1MuA">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D5550156A%26KC%3DA%26FT%3DD&usg=AFQjCNGni8Uz5vEIhu1pRJ3SQqOm0AjvkA">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT128925300" lang="EN" load-source="ifi">Blending docosahexaenoic acid containing microbial oil, a gamma linolenic acid containing oil, adding to infant formula</invention-title></span><br><span class="patent-number">US 5550156 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA37559693" lang="EN" load-source="patent-office"> <div class="abstract">The present invention relates to compositions including blends of microbial oils, methods of using such compositions, particularly as supplements for infant formula, and methods of increasing the amount of long chain polyunsaturated fatty acids in infant formula.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(16)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-8.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-8.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-9.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-9.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-10.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-10.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-11.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-11.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-12.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-12.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-13.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-13.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-14.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-14.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5550156-15.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5550156-15.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(31)</span></span></div><div class="patent-text"><div mxw-id="PCLM5002882" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>We claim:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A process for making a supplement for infant formula consisting essentially of blending a docosahexaenoic acid (DHA)-containing microbial oil and a gamma linolenic acid (GLA)-containing oil, and adding an amount of the blended oils to infant formula, such that the amount of DHA provided by the blend is sufficient to provide an amount of DHA comparable to the amount in human breast milk and the amount of GLA provided by the blend is sufficient to provide GLA in an amount that, upon administration of the formula to an infant, can be converted in the infant's body to an amount of arachidonic acid (ARA) comparable to the amount of ARA obtainable from human breast milk.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The process of claim 1, wherein said linolenic acid-containing oil comprises primrose, borage, or black currant seed oil.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. The process of claim 1, wherein said linolenic acid containing-oil comprises a microbial oil.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. The process of claim 3, further comprising obtaining said linolenic acid-containing oil from Mucor javonicus or Mortierella isabellina.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" class="claim">
      <div class="claim-text">5. The process of claim 1, further comprising blending an EPA-containing oil with said DHA-containing microbial oil and said linolenic acid-containing oil.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" class="claim">
      <div class="claim-text">6. The process of claim 5, wherein said EPA-containing oil comprises fish oil.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" class="claim">
      <div class="claim-text">7. The process of claim 6, wherein said fish oil comprises about one part, said linolenic acid-containing oil comprises about 4 parts and said DHA-containing oil comprises about 1 part by weight of said blend.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. The process of claim 6, wherein said fish oil comprises about one part, said linolenic acid-containing oil comprises about 4 parts and said DHA-containing oil comprises about 1 part by weight of said blend.</div>
    </div>
    </div> <div class="claim"> <div num="9" class="claim">
      <div class="claim-text">9. A composition consisting essentially of a blend of a DHA-containing microbial oil and a gamma linolenic acid-containing oil, in a ratio such that adding to infant formula an amount of the blended oil composition sufficient to provide an amount of the DHA comparable to the amount in human breast milk will provide an amount of GLA in the formula that, upon administration of the formula to an infant, can be converted in the infant's body to an amount of ARA comparable to the amount Of ARA obtainable from human breast milk.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" class="claim">
      <div class="claim-text">10. The composition of claim 9, wherein said linolenic acid-containing oil comprises primrose, borage, or black currant seed oil.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" class="claim">
      <div class="claim-text">11. The composition of claim 9, wherein said linolenic acid containing-oil is an oil obtained from a microbe.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" class="claim">
      <div class="claim-text">12. The composition of claim 11, wherein said microbe comprises Mucor javonicus or Mortierella isabellina.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="13" class="claim">
      <div class="claim-text">13. The composition of claim 9, also comprising an EPA-containing oil, wherein the amount of EPA provided by the blend is less than or equal to one-fifth of the amount of ARA obtained from conversion of GLA in the infant's body.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="14" class="claim">
      <div class="claim-text">14. The composition of claim 13, wherein said EPA-containing oil comprises fish oil.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="15" class="claim">
      <div class="claim-text">15. The composition of claim 14, wherein said fish oil comprises about one part, said linolenic acid-containing oil comprises about 4 parts and said DHA-containing oil comprises about 1 part by weight of said blend.</div>
    </div>
    </div> <div class="claim"> <div num="16" class="claim">
      <div class="claim-text">16. A composition comprising a blend of an oil containing DHA and an oil containing ARA, wherein DHA and ARA are in the form of triglycerides and further wherein at least one of the oil containing DHA and the oil containing ARA is a microbial oil and ARA:EPA ratio of the blend is at least 5:1.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="17" class="claim">
      <div class="claim-text">17. A composition according to claim 16, wherein the oils are blended to provide a ratio of about 2 to 12 parts ARA to about 1 to 5 parts DHA.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="18" class="claim">
      <div class="claim-text">18. A composition in accordance with claim 17, wherein the microbial oil containing DHA comprises about 25-40% DHA.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="19" class="claim">
      <div class="claim-text">19. A composition in accordance with claim 17, wherein the microbial oil containing DHA comprises at least about 35% DHA.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="20" class="claim">
      <div class="claim-text">20. A composition in accordance with claim 17, wherein the microbial oil containing ARA comprises about 20-40% ARA.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="21" class="claim">
      <div class="claim-text">21. A composition in accordance with claim 17, wherein the oils are blended to provide a ratio of ARA:DHA of about 2:1.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="22" class="claim">
      <div class="claim-text">22. The composition according to any one of claims 9 or 17, comprising fish oil blended with at least one microbial oil.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="23" class="claim">
      <div class="claim-text">23. The composition of claim 22, wherein the ratio of fish oil to microbial oil is from 1:1 to 1:15.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="24" class="claim">
      <div class="claim-text">24. A composition according to claim 16, wherein the oils are blended to provide an ARA:DHA:EPA ratio of from about 5 parts ARA and 1 part DHA to about 20 parts ARA and 10 parts DHA to about 1 part EPA.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="25" class="claim">
      <div class="claim-text">25. A composition according to claim 16, comprising a blend of a microbial triglyceride oil containing ARA, and a microbial triglyceride oil containing DHA, wherein the microbial triglyceride oils are blended in amounts to provide a ratio of about 2 to 12 parts ARA to about 1 to 5 parts DHA and said oils further are essentially free of EPA.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="26" class="claim">
      <div class="claim-text">26. A nutritional supplement containing the composition of any one of claims 9, 16 or 17.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="27" class="claim">
      <div class="claim-text">27. A nutritional supplement according to claim 26, comprising a blend of a microbial oil containing DHA and a microbial oil containing ARA, wherein the oils are blended to provide a ratio of about 2 to 12 parts ARA and about 1 to 5 parts DHA, said oils having ARA and DHA in the form of triglycerides.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="28" class="claim">
      <div class="claim-text">28. The nutritional supplement according to claim 26, wherein the supplement is a human nutritional supplement.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="29" class="claim">
      <div class="claim-text">29. The nutritional supplement according to claim 26, wherein the human is a baby.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="30" class="claim">
      <div class="claim-text">30. The nutritional supplement according to claim 26, wherein the human is a pregnant or nursing woman.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="31" class="claim">
      <div class="claim-text">31. A total parenteral nutrition formula containing the composition according to any of claims 9, 16, or 17.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES66820387" lang="EN" load-source="patent-office" class="description">
    <p>This application is a division of application Ser. No. 07/944,739, filed Sep. 14 1993, now U.S. Pat. No. 5,374,657, which is a File Wrapper Continuation of Ser. No. 07/645,457, filed Jan. 24, 1991, now abandoned.</p>
    <p>This invention relates to blends or mixtures of polyunsaturated fatty acid-containing microbial oils and to uses thereof. In a specific preferred embodiment, this invention concerns the use of such oils as an additive or supplement for human diets, for example, as an additive to infant formula.</p>
    <p>It long has been known that long chain polyunsaturated fatty acids (PUFAs) are essential to the human diet, particularly during periods of rapid tissue growth. Sanders et al, Am. J. Clin. Nutr., 31:805-813 (1978). Certain of these long chain acids, such as arachidonic acid (ARA), cannot be synthesized de novo in humans. Only by metabolizing linoleic acid (LOA), which is connected to gamma linolenic acid (GLA), and then to ARA can the human body produce ARA. LOA, in turn, is an essential acid which can only be obtained from dietary sources. Additionally, the presence of eicosapentaenoic acid (EPA) in the diet inhibits the metabolic conversion of LOA to ARA. Carlson, et al., INFORM, 1:306 (1990). ARA and docosahexaneoic acid (DHA) are critical elements of muscle, organ and vascular tissues.</p>
    <p>Infancy is the most significant period of rapid growth in a human's life. An infant can increase its body weight by three times or more during its first year of life. Accordingly, it is critical that the infant receive adequate amounts of PUFAs to insure proper structural and organ development. Human breast milk contains high levels of PUFAs in which the ratio of ARA to EPA is typically about 20:1. However, many women choose not to breast feed their infants for either part or all of the first year of the infant's life.</p>
    <p>As recognized by Clandinin et al., U.S. Pat. No. 4,670,285, incorporated herein by reference, available infant formulas are deficient in long chain (C<sub>20</sub> and C<sub>22</sub>) PUFAs. Clandinin et al. disclose an infant formula prepared from a blend of vegetable oil and egg yolk lipid and/or fish oil which can provide a total fat composition comparable to that of human breast milk. A preferable composition comprises from 75 to 95 parts by weight egg yolk and 5 to 25 parts vegetable oil. This composition is the entire lipid content of the infant formula and it is not economical to prepare. Additionally, the infant formula disclosed by Clandinin et al. results in an EPA level which is 16 times higher than the level of EPA in human breast milk and an ARA level which is only one quarter that of breast milk.</p>
    <p>DE 3603000A1 (Milupa) discloses a computer profile of a highly polyunsaturated acid fat mixture and discusses the use of such a mixture to produce infant formulas. Sources of the fatty acids are listed as certain types of macroalgae (i.e. seaweed), fish oil, organ fats from beef and pork, and highly refined egg yolk oil. In addition to DHA from fish oil, a potential source of DHA and ARA is said to be macroalgae, but only of the seaweed types. There is no suggestion to use microbes of any type, much less microbial oil.</p>
    <p>Methods of producing microbial oils are disclosed in the following references, each of which is incorporated herein by reference. U.S. Pat. No. 5,244,912 discloses the production of eicosapentaneoic acid-containing single cell oils (EPASCO). U.S. Pat. No. 5,407,957 discloses the production of docosahexaneoic acid-containing single cell oil (DHASCO). Co-pending U.S. patent application Ser. No. 07/645,454, now abandoned filed concurrently with the present application and assigned to the same assignee, relates to the production of arachidonic acid-containing single cell oil (ARASCO). EP322,227 also discloses a microbial oil production system. None these references teach the use of blends containing unmodified microbial oils as a dietary supplement, or the use of a blend of microbial oils as an additive to existing infant formula to provide that formula with a long chain PUFA composition similar to breast milk.</p>
    <p>Accordingly, it is an object of the present invention to provide a PUFA-enriched additive, the composition of which when added to commercial infant formula will provide desired long chain PUFAs in amounts comparable to the amounts of those PUFAs found in human breast milk.</p>
    <p>It is an additional object of the present invention to provide an economical method of producing the above-described composition.</p>
    <p>These, and other, objects are satisfied by the present invention as described herein.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>This invention relates to the use of microbial oils which contain long chain polyunsaturated fatty acids. Additionally, in various embodiments, fish oil and/or vegetable oils can be blended with such microbial oils to form desired compositions. The compositions can be used as dietary supplements, particularly as additives for infant formula, as well as for pharmaceutical and cosmetic applications.</p>
    <p>The invention also relates to economically viable processes for altering the long chain polyunsaturated fatty acid composition of infant formula and/or baby food. Preferably, the altered composition resembles that of human breast milk.</p>
    <heading>DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT OF THE INVENTION</heading> <p>Broadly stated, the present invention concerns blends, or mixtures, containing unmodified microbial oils. As used herein, "unmodified" means not chemically or covalently altered. It will be understood that throughout this specification references to "microbial oil" or "oil" mean, unless otherwise specifically stated, unmodified oil. "Microbial oils" or "single cell oils" are those oils naturally produced by microorganisms during their lifespan. Such oils can be high in long chain PUFAs. The applicant has discovered that certain of these oils, when blended with other microbial oils, fish oils, vegetable oils, or any combination thereof, can produce a composition useful for dietary, pharmaceutical or cosmetic purposes.</p>
    <p>Various microbial oils, for example, can be obtained by, for example, the processes disclosed in above-referenced U.S. Pat. Nos. 5,244,921, 5,407,957 EP322,227 (Yamada et al., Suntory) or U.S. patent application Ser. No. 07/645,454, now abandoned (the latter having been filed concurrently with the present application and assigned to the same assignee). The disclosure of each of these references is specifically incorporated by reference herein.</p>
    <p>It is to be understood that the present invention encompasses the use of a single-microbial oil containing at least two desirable PUFAs, such as ARA and DHA. The oils specifically disclosed and utilized herein, however, each contain a single desirable PUFA.</p>
    <p>Any non-toxic, PUFA-containing microbial oil can be used in the present invention. The most preferred microbial oils are those rich in an omega-3 or omega-6 PUFA, especially DHA, GLA or ARA. These PUFAs typically are missing from, or are inadequately provided in, dietary supplements such as infant formulas or baby food. "Infant formula" as used herein means an enteral nutritional product which can be substituted for human breast milk in feeding infants and typically is composed of a desired percentage of fat mixed with desired percentages of carbohydrates and proteins in an aqueous solution. Frequently micronutrients, such as trace metals and vitamins or other desired additives are present. An exemplary formula is disclosed by Clandinin et al., U.S. Pat. No. 4,670,285, the disclosure of which is incorporated herein by reference.</p>
    <p>In the present invention, types of oils from different microbes can be mixed together to obtain a desired composition. Alternatively, or additionally, PUFA-containing microbial oil can be blended with fish oil, vegetable oil or a mixture of both to obtain a desired composition.</p>
    <p>An objective in mixing the oils is to obtain an additive which will provide an infant formula with a desired omega-3 and omega-6 PUFA composition similar to that found in breast milk. While the proportion of the desired fatty acids in a microbial oil can vary, this proportion can easily be determined and the amount of oil adjusted to provide the desired amount of PUFA. Similarly, the percentage of desired PUFA in fish oil or vegetable oils can easily be determined and the amount of the oil to be added can be adjusted as necessary to achieve the desired results.</p>
    <p>"Fish oils" are those oils obtained from fish. Such oils typically contain DHA in amounts ranging from 3% to about 20%. Typically, however, fish oils also contain EPA which depresses the production of ARA in the body. The addition of a microbial oil containing high levels of ARA to fish oil-containing compositions substantially overcomes that problem.</p>
    <p>"Vegetable oil" includes all those oils from plants which contain long chain PUFAs. Typically, vegetable oils do not contain long chain PUFAs (PUFAs at least 20 carbons long), which is why animal organ oils are usually characterized as the source of PUFAs. Thus, vegetarians, especially vegetarian mothers, can have a diet containing inadequate amounts of PUFAs. Vegetable oils known to contain PUFAs may contain GLA. GLA is a C18:3 omega-6 PUFA. Such oils include black currant seed oil, borage oil and primrose oil. While GLA is the metabolic precursor to ARA, the process of conversion is very slow, requiring the participation of the enzyme Δ6-desaturase. This enzyme is present in humans in very low levels. Burre, et al., Lipids, 25:354-356 (1990). Thus, it would be preferable to provide the body with ARA rather than its precursor, GLA.</p>
    <p>Methods for isolating vegetable oils are known to those of skill in the art and do not comprise a part of the present invention. Additionally, certain fungi produce PUFA-containing oils. For example, Mucor species produce a GLA-containing oil.</p>
    <p>DHASCO, defined herein as docosahexaneoic acid-containing single cell oil, can be obtained, for example, from Crypthecodinium cohnii as disclosed in above-referenced U.S. Pat. No. 5,407,957. DHA is a C22:6 omega-3 long chain PUFA.</p>
    <p>EPASCO, defined herein as eicosapentaneoic acid-containing single cell oil, can be obtained, for example, from Nitzschia alba as disclosed in above-referenced U.S. Pat. No. 5,244,921. EPA is a C20:5 omega-3 long chain PUFA.</p>
    <p>ARASCO, defined herein as arachidonic acid-containing single cell oil, can be obtained from species such as Pythium insidiosum, or Mortierella alpina, as described in U.S. application Ser. No. 07/645,454 filed concurrently herewith. ARA is a C20:4 omega-6 long chain PUFA.</p>
    <p>Of those fungal species which previously have had their fatty acids characterized, it has been found that most do not make ARA. Weete, J. D., Fungal Lipid Biochemistry, Plenum Press, NY (1974). Of those species which do make ARA, many, including all previously characterized Pythium species, produce significant quantities of eicosapentaenoic acid (EPA) in addition to ARA. Table 1 sets forth the fatty acid profile of P. insidiosum as well as the fatty acid profile of other species of fungi. Unexpectedly, it has been found that P. insidiosum produces ARA without concomitant production of EPA. As with fish oils, high EPA levels in dietary supplements result in a depression of the ability to form ARA from dietary linoleic acid (LOA). Accordingly, while those fungal species producing both ARA and EPA can be utilized in the process of this invention, it is preferable to use species which do not produce significant quantities of EPA. Such preferred species include Pythium insidiosum and Mortierella alpina. Both species are available commercially and are on deposit with the American Type Culture Collective in Rockville, Md., having accession numbers 28251 and 42430, respectively. Throughout this disclosure, unless otherwise expressly stated, P. insidiosum will be the representative fungal species.</p>
    <p>One of the significant problems which an embodiment of the present invention overcomes, is the depression of ARA biosynthesis in infants caused by the presence of enhanced dietary levels of EPA. This problem can be corrected by providing ARA for use in infant formula at levels substantially similar to those found in human breast milk. Typically in human breast milk, the ratio of ARA:EPA is about 20:1 respectively. The present invention specifically contemplates any microbial oil which provides a sufficient amount of ARA to overcome the negative effects of dietary EPA. Preferably, the use of the ARA-containing oil will result in an ARA:EPA ration of at least about 5:1. More preferably, the ratio will be at least about 10:1 and, most preferably, it will be at least about 20:1. As can be seen, the higher the amount of ARA in the end product, with respect to the amount of EPA, the more desirable is the result.</p>
    <p>In a process of the present invention, the fungi are cultivated under suitable ARA-containing oil producing cultivating conditions. In general, techniques of fungal cultivation are well known to those of skill in the art and those techniques can be applied to the present inventive process. For example, cultivation of an inoculating amount of fungus can occur in submerged culture in shake flasks. The flask is provided with a growth medium, seeded with fungal mycelium, and grown on a reciprocating shaker for about three to four days.</p>
    <p>The composition of the growth medium can vary but always contains carbon and nitrogen sources. A preferred carbon source is glucose, amounts of which can range from about 1. 0-100 grams glucose per liter of growth medium. Typically about 15 grams/liter are utilized for shaker flask culture. The amount can be varied depending upon the desired density of the final culture. Other carbon sources which can be used include molasses, high fructose corn syrup, hydrolyzed starch or any other low cost conventional carbon source used in fermentation processes. Additionally, lactose can be provided as a carbon source for P. insidiosum. Thus, whey permeate, which is high in lactose and is a very low cost carbon source, can be used as a substrate. Suitable amounts of these carbon sources can readily be determined by those of skill in the art. Usually, additional carbon needs to be added during the course of the cultivation. This is because the organisms use so much carbon that adding it all in a batch mode could prove unwieldy.</p>
    <p>Nitrogen typically is provided in the from of yeast extract at a concentration of from about 2 to about 15 grams extract per liter of growth medium. Preferably, about four grams per liter are provided. Other nitrogen sources can be used, including peptone, tryptone, cornsteep liquor, etc. The amount to be added of these sources can easily be determined by those of skill in the art. Nitrogen can be added in a batch mode, i.e. all at one time prior to cultivation.</p>
    <p>After cultivation for 3-4 days at a suitable temperature, typically about 25°-30° C., an amount of fungi has grown which is sufficient for use as an inoculum in a conventional stirred tank fermentor (STF). Such fermentors are known to those of skill in the art and are commercially available. Fermentation can be carried out in batch, fed-batch, or continuous fermentation modes. Preferably, the STF is equipped with a Rushton-type turbine impeller.</p>
    <p>The fermentor is prepared by adding the desired carbon and nitrogen sources. For example, a 1.5 liter fermentor can be prepared by mixing about 50 grams of glucose and about 15 grams of yeast extract per liter of tap water. As previously discussed, other carbon or nitrogen sources or mixtures thereof can be used.</p>
    <p>The reactor containing the nutrient solution should be sterilized by, for example, heating prior to inoculation. After cooling to about 30° C., the inoculum can be added, and cultivation initiated. Gas exchange is provided by air sparging. The air sparging rate can vary, but preferably is adjusted to from about 0.5 to about 4.0 VVM (volume of air per volume of fermentor per minute). Preferably the dissolved oxygen level is kept at from about 10% to about 50% of the air saturation value of the solution. Accordingly, adjustments in the sparge rate may be required during cultivation. Agitation is desirable. The agitation is provided by the impeller. Agitation tip speed preferably is set within the range of from about 50 cm/sec to about 500 cm/sec, preferably from about 100 to 200 cm/sec.</p>
    <p>In general, the amount of inoculum can vary. Typically, from about 2% to about 10% by volume of inoculum can be used. Preferably, in a fermentor seed train about 5% by volume of inoculum can be used.</p>
    <p>Nutrient levels should be monitored. When glucose levels drop below 5 g/l, additional glucose should be added. A typical cultivation cycle utilized about 100 grams of glucose and about 15 grams of yeast extract per liter. It is desirable to deplete the nitrogen during the course of the cultivation as this enhances oil production by the fungi. This is especially true when M. alpina is used as the production organism.</p>
    <p>Occasionally, the culture will produce an excessive quantity of foam. Optionally, an antifoaming agent, such as those known to those of skill in the art, e.g. Mazu 310®, can be added to prevent foam.</p>
    <p>The temperature of cultivation can vary. However, those fungi which produce both ARA and EPA tend to produce less EPA and more ARA when cultivated at higher temperatures. For example, when Mortierella alpina is cultivated at less than 18° C., if begins to produce EPA. Thus, it is preferable to maintain the temperature at a level which induces the preferential production of ARA. Suitable temperatures are typically from about 25 ° C. to about 30° C.</p>
    <p>Preferably, cultivation continues until a desired biomass density is achieved. A desirable biomass is about 25 g/l of the organism. Such a biomass typically is attained within 48-72 hours after inoculation. At this time, the organisms typically contain about 5-40% complex lipids, i.e. oil, of which about 10-40% is ARA, and can be harvested.</p>
    <p>Harvesting can be done by any suitable method such as, for example, filtration, centrifugation, or spray drying. Because of lower cost, filtration may be preferred.</p>
    <p>After harvesting, the mycelial cake can be extracted. The mycelial cake refers to the collection of biomass resulting after harvest. The cake can be loose or pressed, crumbled or uncrumbled. Optionally, the cake can have any residual water removed, as by vacuum drying or lyophilization, prior to extraction. If this option is selected, it is preferable to use nonpolar solvents to extract the ARA-containing oil. While any non-polar extract is suitable, hexane is preferred.</p>
    <p>Alternatively, the wet cake (which typically contains about 30-50% solids) can be crumbled and extracted directly using polar solvents such as ethanol or isopropyl alcohol, or supercritical fluid extraction with solvents such as CO<sub>2</sub> or NO. Preferably, the cakes are crumbled prior to extraction. Advantageously, the present invention permits the economical use of supercritical fluid extraction techniques. McHugh, et al., Supercritical Fluid Extraction, Butterworth (1986). Such techniques are known to those of skill in the art and include those presently applied, for example, to decaffeinate coffee beans. While the yields from both wet and dry extractions are similar, wet extraction generally is a more economical process.</p>
    <p>Another aspect of the invention discloses a process for supplementing or altering the composition of commercially available infant formula so as to provide them with a PUFA composition more nearly like that typically contained in human breast milk. "Typical" as used herein refers to the average amounts of PUFAs measured. One of the advantages of the present invention is that, if desired, a nursing mother choosing to switch to formula can have her breast milk analyzed for PUFA content. Then, an additive for a commercially available formula which will supply comparable amounts of PUFAs can be specifically designed. Long chain PUFA-containing microbial oils from at least two microorganisms can be obtained and blended together to provide the desired composition. The blend then can be added to an infant formula. Preferably, an amount of the blend effective to provide an amount of the desired PUFAs substantially similar to that found in human breast milk will be provided.</p>
    <p>Typically, human breast milk contain from about 0.5 to 0.6% of its fatty acid content as ARA, from about 0.15 to about 0.36% of its fatty acid content as DHA and from about 0.03 to about 0.13% of its fatty acid content as EPA. Thus, a preferred ratio of ARA:DHA:EPA is from about 5:1:1 to about 20:10:1 respectively. Amounts of oils providing approximately these ratios of PUFAs can be determined without undue experimentation by those of skill in the art.</p>
    <p>In a preferred embodiment, the microbial oils include ARASCO and DHASCO and EPASCO or any combination thereof. It is also preferred to use oil from microbes of the genera Mortierella, Pythium, Crypthecodinium, and Nitzschia or any combination thereof. Particularly preferred species from these genera are M. alpina, P. insidiosum, C. cohnii and N. alba. This preferred embodiment would provide an acceptable alternative for vegetarians, including breast-feeding or pregnant vegetarian women.</p>
    <p>If desired, fish oil can be blended, or mixed, with any combination of, or individual, microbial oil to produce a composition which, when subsequently added to infant formula will alter the PUFA content thereof in a desirable manner. Such a composition would not be suitable for a strict vegetarian intake. A preferred fish oil is specially processed Menhaden Oil (produced by Zapata Hayne, Inc.) which typically contains about 9% DHA. Of course, other fish oils also can be used.</p>
    <p>When DHASCO is to be blended with ARASCO, and no other PUFA-containing oils are to be utilized, it is desirable to blend sufficient amounts of the oils to provide from about 1 to about 5 parts DHA with from about 2 to about 12 parts ARA. A most preferred ratio of DHA to ARA is 1:3 respectively.</p>
    <p>As another example, Menhaden fish oil, as noted above, typically contains about 9% by weight DHA. ARASCO typically contains about 20-40% by weight ARA. DHASCO typically contains about 25-40% by weight DHA. It has been found that a blend of 1 part Menhaden oil containing about 9% by weight DHA with 10 parts ARASCO containing about 33% by weight ARA and 3 parts DHASCO containing about 35% by weight DHA, when added to infant formula, causes the infant formula to closely approximate the ARA and DHA content of human breast milk. Other ratios can be readily calculated.</p>
    <p>In another embodiment of the present invention is disclosed a process for making a supplement for infant formula or baby food which entails blending a DHA- containing oil with a GLA-containing oil. It is to be understood that, in general, any combination of GLA- EPA- ARA- or DHA-containing oils, with or without fish oil, can be used. The source of the GLA can be a vegetable oil, such as primrose, black currant or borage oil, or a microbial oil such as the oil from Mucor javonicus or Mortierella isabellina, for example. Table 1 sets forth the GLA composition of such oils. In a preferred aspect of this embodiment, about 1 part of Menhaden oil containing about 9% DHA, about 4 parts of GLA-containing oil containing about 18% GLA from black currant seed, and about 1 part of DHASCO containing about 33% DHA are blended together. Other ratios can be selected as desired.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 1______________________________________Fatty acids of commercially available oils containing GLA(from Lawson and Hughes, 1988 and Suzuki, 1989)Relative % of total acyl groups in oil from:Fatty acyl   Mucor     Mortierella                       Evening                              Black-group   javanicus*             isabellina**                       Primrose                              currant                                    Borage______________________________________14:0    1.0       0.7       --     --    --14:1    0.1       --        --     --    --16:0    18.6      27.2      5.9    6.9   10.716:1    1.0       0.9       --     --    --18:0    7.1       5.7       1.8    1.3   3.018:1    39.9      43.9      7.5    10.8  15.418:2    8.9       12.0      74.8   46.7  38.1-18:3(6)   17.9      8.3       9.3    15.9  24.8α-18:3(3)   --        --        --     13.0  --18:4(3) --        --        --     2.9   --20:0    --        0.6       --     --    --20:1(9) --        --        --     --    4.022:0    --        0.1       --     --    --22:1(9) --        0.2       --     --    2.224:0    0.6       --        --     --    --______________________________________ *Produced by J. &amp; E. Sturge Ltd., Selby, N. Yorks., U.K. **Produced by Idemitzu Petro Chemical Co. Ltd., Tokyo, Japan. Lawson  Lipids 23:313-317 (1988) Suzuki  In Biotechnology for the Fats and Oils Industry p.110-116. Amer Oil Chem. Soc. Press (1989).</pre>
    
    <p>A composition including a blend of any combination of the above-described microbial-oils with or without either, or both, fish oil and vegetable oil is another aspect of the present invention. While the composition includes any ratios of the oils, the ratios previously described are preferred.</p>
    <p>In another preferred embodiment, the composition serves as a nutritional supplement. Typically, such supplements are encapsulated, such as in gelatin capsules. Such capsules provide an easy form of administration to persons having a need for supplementation, such as pregnant or nursing women. However, parenteral administration is a viable option and in one embodiment the composition comprises the fat component of a total parenteral nutritional formula. Such formulas are known and commercially available.</p>
    <p>As will be understood, the composition of the present invention is particularly useful as a dietary supplement for pregnant or nursing women. Vegetarian women, in particular, may require increased amounts of DHA and ARA, yet have been precluded from obtaining such in the past because the only available sources were animal.</p>
    <p>The invention having been previously described in general, reference is now had to the following nonlimiting examples for illustrative purposes only.</p>
    <heading>EXAMPLES</heading> <heading>Example 1</heading> <p>Preparation of Oil Mix #1 and addition to infant formula.</p>
    <p>The first mixture represents a totally vegetarian source of an arachidonic and docosahexaenoic acid supplement. This supplement would be considered acceptable to persons restricted to a vegetarian diet. Sanders et al. (Amer. J. Clin. Nutr. 31:705; 1978) have reported that the DHA levels in the breast milk of vegetarian mothers are depressed. Enteral supplementation of a blend of DHA single cell oil and ARA single cell oil will elevate the serum and, hence, breast milk levels of DHA to that of omnivorous mothers. This blend is prepared by mixing one part DHASCO containing about 35% DHA (obtained from Crypthecodinium cohnii as described in U.S. Pat. No. 5,407,957 and deposited with the American Type Culture Collection in Rockville, Maryland (ATCC) having accession number 40750) with three parts ARASCO containing about 33% ARA (obtained from Pythium insidiosum as described in U.S. application Ser. No. 07/645,454, now abandoned and on deposit with the ATCC, having accession number 28251). The resulting mixture, or blend, has the fatty acid composition shown in Table 2. The blend is mixed in a ratio of one part blend to forty parts of the oils regularly in infant formula, typically about 2.8-3.0 grams per 100 ml of formula. At a normal fat content of 30g fat per liter of Similac® infant formula, this corresponds to the addition of 750 mg per liter of prepared formula. This supplement provides ARA and DHA levels equivalent to human breast milk.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 2______________________________________Composition of a blend of DHA oil and ARA oil inproportions of 1:3 by weight             Infant               breastFatty Acid   oil mix #1             formula  formula + mix #1                                  milk______________________________________8:0 + 10:0   0.00      41.8     40.78       1.7412:0 + 14:0   13.63     20.7     20.53       14.9516:0    17.05     6.8      7.05        19.8216:1    7.88      0.2      0.39        3.2018:0    0.00      2.3      2.24        5.9118:1    7.48      10.0     9.94        34.8218:2 n6 7.20      17.4     17.15       16.0018:3 n3 2.25      0.9      0.93        0.6218:3 n6 4.50      --       0.11        0.0020:1    --        0.1      0.10        1.1020:2 n6 --        --       0.00        0.6120:3 n6 --        --       0.00        0.4220:4 n6 24.75     --       0.60        0.5920:5 n3 --        --       0.00        0.0322:1    --        --       0.00        0.1022:4 n6 --        --       0.00        0.2122:5 n6 --        --       0.00        0.2222:6 n3 8.98      --       0.22        0.19______________________________________</pre>
    
    <heading>Example 2</heading> <p>Preparation of Oil Mix #2 and addition to infant formula.</p>
    <p>This mixture represents a totally vegetarian source of long chain PUFAs and would be considered acceptable to persons restricted to a vegetarian diet. This blend is prepared by mixing three parts DHASCO containing about 35% DHA (obtained from Crypthecodinium cohnii as described in U.S. Pat. No. 5,407,957 with ten parts ARASCO containing about 33% ARA (obtained from Pythium insidiosum as described in U.S. application Ser. No. 07/645,454 filed concurrently herewith) and five parts EPASCO containing about 5% EPA (obtained from N. alba on deposit with the ATCC as described in U.S. Pat. No. 5,244,921. The resulting mixture, or blend, has the fatty acid composition shown in Table 3. The blend is mixed in a ratio of one part blend to thirty parts of the oils regularly in infant formula. At a normal fat content of 30g fat per liter of Similac® infant formula, this would correspond to the addition of one gram per liter of prepared formula. This supplement provides ARA, DHA and EPA levels equivalent to human breast milk.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 3______________________________________Composition of a blend of DHA oil, ARA oil and EPA oilin proportions of 3:10:5 by weight             Infant               breastFatty Acid   oil mix #2             formula  formula + mix #2                                  milk______________________________________8:0 + 10:0   0.00      41.8     40.45       1.7412:0 + 14:0   16.64     20.7     20.57       14.9516:0    21.61     6.8      7.28        19.8216:1    6.55      0.2      0.40        3.2018:0    0.28      2.3      2.23        5.9118:1    12.91     10.0     10.09       34.8218:2 n6 5.87      17.4     17.03       16.0018:3 n3 1.88      0.9      0.93        0.6218:3 n6 3.48      --       0.11        0.0020:1    --        0.1      0.10        1.1020:2 n6 --        --       0.00        0.6120:3 n6 0.19      --       0.01        0.4220:4 n6 18.52     --       0.60        0.5920:5 n3 0.76      --       0.02        0.0322:1    --        --       0.00        0.1022:4 n6 0.11      --       0.00        0.2122:5 n6 --        --       0.00        0.2222:6 n3 6.24      --       0.20        0.19______________________________________</pre>
    
    <heading>Example 3</heading> <p>Preparation of Oil Mix #3 and addition to infant formula.</p>
    <p>This mixture is a blend of ARASCO with fish oils. Oil mixture #3 is prepared by adding one part specially processed Menhaden Oil (Zapata Hayne Inc.) containing about 9% DHA to one part of ARASCO, obtained from Pythium insidiosum as described previously containing about 33% ARA. The resultant fatty acid composition is shown in Table 4. This blend is mixed in a ratio of one part blend to thirty parts of the oils regularly in infant formula. At a normal fat content of 30 g fat per liter of infant formula, this corresponds to the addition of 1 gram per liter of prepared formula. This supplement provides ARA and DHA levels equivalent to human breast milk, but the EPA levels are about eight-fold higher than those in breast milk.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 4______________________________________Composition of a blend of SPMO* and ARA oil inproportions of 1:1 by weight.             Infant               breastFatty Acid   oil mix #3             formula  formula + mix #3                                  milk______________________________________8:0 + 10:0   0.0       41.8     40.45       1.7412:0 + 14:0   10.2      20.7     20.36       14.9516:0    15.5      6.8      7.08        19.8016:1    11.5      0.2      0.56        3.2018:0    1.41      2.3      2.27        5.9118:1    8.79      10.0     9.96        34.8218:2 n6 5.57      17.4     17.02       16.0018:3 n3 2.31      0.9      0.95        0.6218:3 n6 3.00      --       0.10        0.0020:1    0.78      0.1      0.12        1.1020:2 n6 0.00      --       0.00        0.6120:3 n6 0.00      --       0.00        0.4220:4 n6 17.52     --       0.57        0.5920:5 n3 7.76      --       0.25        0.0322:1    0.00      --       0.00        0.1022:4 n6 0.00      --       0.00        0.2122:5 n6 1.21      --       0.04        0.2222:6 n3 4.57      --       0.15        0.19______________________________________ * Specially Processed Menhaden Oil.</pre>
    
    <heading>Example 4</heading> <p>Preparation of Oil Mix #4 and addition to infant formula</p>
    <p>Oil mixture #4 was developed to utilize GLA in place of arachidonic acid. This blend was prepared by mixing one part specially prepared Menhaden oil containing about 9% DHA (Zapata Hayne Inc.) with four parts black currant seed oil containing about 18% GLA and one part DHASCO containing about 35% DHA. The resultant fatty acid composition is shown in Table 5. This blend is mixed in a ratio of one part blend to forty parts of the oils regularly in infant formula. At a normal fat content of 30g fat per liter, this would correspond to the addition of 750 mg per liter of prepared formula. This supplement provides EPA and DHA levels equivalent to human breast milk. The ARA levels are about one tenth the level in human breast milk. However, the GLA levels are twenty to fifty times higher than the GLA levels in breast milk which typically are minute.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 5______________________________________Composition of a blend of SPMO, BCO and DHA oil inproportions of 1:4:1 by weight.             Infant               breastFatty Acid   oil mix #4             formula  formula + mix #4                                  milk______________________________________8:0 + 10:0   0.0       41.8     40.78       1.7412:0 + 14:0   4.83      20.7     20.31       14.9516:0    11.86     6.8      6.92        19.8016:1    2.09      0.2      0.25        3.2018:0    1.34      2.3      2.28        5.9118:1    10.98     10.0     10.02       34.8218:2 n6 31.39     17.4     17.74       16.0018:3 n3 8.94      0.9      1.10        0.6218:3 n6 10.60     --       0.26        0.0020:1    0.26      0.1      0.10        1.1020:2 n6 --        --       0.00        0.6120:3 n6 --        --       0.00        0.4220:4 n6 0.34      --       0.06        0.5920:5 n3 2.59      --       0.00        0.0322:1    --        --       0.00        0.1022:4 n6 --        --       0.00        0.2122:5 n6 0.40      --       0.01        0.2222:6 n3 7.51      --       0.18        0.19______________________________________</pre>
    
    <heading>Example 5</heading> <p>Preparation of Oil Mix #5 and addition to infant formula</p>
    <p>Oil mixture #5 was developed to best approximate the composition of DHA, ARA and EPA of human breast milk. This oil blend was prepared by mixing one part specially prepared Menhaden oil containing about 9% DHA (Zapata Hayne Inc.) with ten parts of ARASCO containing about 33% ARA and three parts DHASCO containing about 35% DHA. The resultant fatty acid composition is shown in Table 6. This blend is mixed in a ratio of one part blend to forty parts of the oils regularly in infant formula. At a normal fat content of 30g fat per liter of infant formula, this corresponds to the addition of 750 mg per liter of prepared formula. This supplement provides EPA, DHA and ARA levels substantially equivalent to those levels in human breast milk.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 6______________________________________Composition of a blend of SPMO, ARA oil and DHA oilin proportions of 1:10:3 by weight.             Infant               breastFatty Acid   oil mix #5             formula  formula + mix #5                                  milk______________________________________8:0 + 10:0   0.00      41.8     40.78       1.7412:0 + 14:0   13.14     20.7     20.52       14.9516:0    16.83     6.8      7.04        19.8016:1    8.39      0.2      0.40        3.2018:0    0.20      2.3      2.25        5.9118:1    7.66      10.0     9.94        34.8218:2 n6 6.97      17.4     17.15       16.0018:3 n3 2.26      0.9      0.93        0.6218:3 n6 0.25      --       0.01        0.0020:1    0.11      0.1      0.10        1.1020:2 n6 --        --       0.00        0.6120:3 n6 --        --       0.00        0.4220:4 n6 23.72     --       0.58        0.5920:5 n3 1.11      --       0.03        0.0322:1    --        --       0.00        0.1022:4 n6 --        --       0.00        0.2122:5 n6 0.17      --       0.00        0.2222:6 n3 8.35      --       0.20        0.19______________________________________</pre>
    
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US2611706">US2611706</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 21, 1949</td><td class="patent-data-table-td patent-date-value">Sep 23, 1952</td><td class="patent-data-table-td ">Wyeth Corp</td><td class="patent-data-table-td ">Fat composition for infants&#39; food</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US2923628">US2923628</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 4, 1957</td><td class="patent-data-table-td patent-date-value">Feb 2, 1960</td><td class="patent-data-table-td ">Otto Harold L</td><td class="patent-data-table-td ">Synthetic milk</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3458625">US3458625</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 22, 1963</td><td class="patent-data-table-td patent-date-value">Jul 29, 1969</td><td class="patent-data-table-td ">Quaker Oats Co</td><td class="patent-data-table-td ">Ruminant feeding</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3542560">US3542560</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 6, 1967</td><td class="patent-data-table-td patent-date-value">Nov 24, 1970</td><td class="patent-data-table-td ">American Home Prod</td><td class="patent-data-table-td ">Infant formula with fat composition like human milk</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3649295">US3649295</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 1, 1970</td><td class="patent-data-table-td patent-date-value">Mar 14, 1972</td><td class="patent-data-table-td ">American Home Prod</td><td class="patent-data-table-td ">Humanized fat compositions and infant formulas thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4058594">US4058594</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 10, 1976</td><td class="patent-data-table-td patent-date-value">Nov 15, 1977</td><td class="patent-data-table-td ">John Williams</td><td class="patent-data-table-td ">Immuno-suppressive agents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4216236">US4216236</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 11, 1978</td><td class="patent-data-table-td patent-date-value">Aug 5, 1980</td><td class="patent-data-table-td ">Societe D&#39;assistance Technique Pour Produits Nestle S.A.</td><td class="patent-data-table-td ">Infant milk formula and process for its manufacture</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4282265">US4282265</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 14, 1980</td><td class="patent-data-table-td patent-date-value">Aug 4, 1981</td><td class="patent-data-table-td ">Bristol-Myers Company</td><td class="patent-data-table-td ">Fat compositions for infant formulas</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4303692">US4303692</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 2, 1979</td><td class="patent-data-table-td patent-date-value">Dec 1, 1981</td><td class="patent-data-table-td ">Gaull Gerald E</td><td class="patent-data-table-td ">Taurine additive</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4513008">US4513008</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 30, 1982</td><td class="patent-data-table-td patent-date-value">Apr 23, 1985</td><td class="patent-data-table-td ">The Vinoxen Company, Inc.</td><td class="patent-data-table-td ">Virucidal compositions and therapy</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4526793">US4526793</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 6, 1983</td><td class="patent-data-table-td patent-date-value">Jul 2, 1985</td><td class="patent-data-table-td ">Nestec, S.A.</td><td class="patent-data-table-td ">Linolenic acid triglyceride, fatty acid triglyceride, edible oil</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4526902">US4526902</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 24, 1983</td><td class="patent-data-table-td patent-date-value">Jul 2, 1985</td><td class="patent-data-table-td ">Century Laboratories, Inc.</td><td class="patent-data-table-td ">Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4544559">US4544559</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 15, 1982</td><td class="patent-data-table-td patent-date-value">Oct 1, 1985</td><td class="patent-data-table-td ">Union Industrial Y Agroganadera, S.A. (Uniasa)</td><td class="patent-data-table-td ">Nucleotide enriched humanized milk and process for its preparation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4614663">US4614663</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 3, 1985</td><td class="patent-data-table-td patent-date-value">Sep 30, 1986</td><td class="patent-data-table-td ">John Wyeth &amp; Brother Ltd.</td><td class="patent-data-table-td ">Fat compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4670285">US4670285</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 14, 1985</td><td class="patent-data-table-td patent-date-value">Jun 2, 1987</td><td class="patent-data-table-td ">The University Of Toronto Innovations Foundation</td><td class="patent-data-table-td ">Infant formula</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4681896">US4681896</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 31, 1984</td><td class="patent-data-table-td patent-date-value">Jul 21, 1987</td><td class="patent-data-table-td ">Efamol Limited</td><td class="patent-data-table-td ">Pharmaceutical and dietary composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4752618">US4752618</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 12, 1984</td><td class="patent-data-table-td patent-date-value">Jun 21, 1988</td><td class="patent-data-table-td ">New England Deaconess Hospital</td><td class="patent-data-table-td ">Using fatty acid oils</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4780456">US4780456</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 20, 1987</td><td class="patent-data-table-td patent-date-value">Oct 25, 1988</td><td class="patent-data-table-td ">Crinos Industria Farmacobiologica S.P.A.</td><td class="patent-data-table-td ">Pharmaceutical or dietetic composition having a high antiarteriosclerotic activity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4792418">US4792418</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 19, 1985</td><td class="patent-data-table-td patent-date-value">Dec 20, 1988</td><td class="patent-data-table-td ">Century Laboratories, Inc.</td><td class="patent-data-table-td ">Method of extraction and purification of polyunsaturated fatty acids from natural sources</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4810497">US4810497</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 22, 1988</td><td class="patent-data-table-td patent-date-value">Mar 7, 1989</td><td class="patent-data-table-td ">Efamol Limited</td><td class="patent-data-table-td ">Pharmaceutical compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4820731">US4820731</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 15, 1988</td><td class="patent-data-table-td patent-date-value">Apr 11, 1989</td><td class="patent-data-table-td ">New England Deaconess Hospital Corporation</td><td class="patent-data-table-td ">Parenteral dietary supplement and method of minimizing effects of infection through diet</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4826877">US4826877</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 26, 1986</td><td class="patent-data-table-td patent-date-value">May 2, 1989</td><td class="patent-data-table-td ">Efamol Limited</td><td class="patent-data-table-td ">Polyunsaturated acids to treat diabetic neuropathy</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4843095">US4843095</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 7, 1987</td><td class="patent-data-table-td patent-date-value">Jun 27, 1989</td><td class="patent-data-table-td ">Century Laboratories, Inc.</td><td class="patent-data-table-td ">Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4851343">US4851343</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 19, 1985</td><td class="patent-data-table-td patent-date-value">Jul 25, 1989</td><td class="patent-data-table-td ">Efamol Limited</td><td class="patent-data-table-td ">Biosynthesisof linolenic acid/g-/ using rhizopus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4868001">US4868001</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 31, 1988</td><td class="patent-data-table-td patent-date-value">Sep 19, 1989</td><td class="patent-data-table-td ">Kazumitsu Maruta</td><td class="patent-data-table-td ">Feed for animals and process for producing same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4874603">US4874603</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 15, 1988</td><td class="patent-data-table-td patent-date-value">Oct 17, 1989</td><td class="patent-data-table-td ">Uwe Fratzer</td><td class="patent-data-table-td ">Use of vitamin E for normalization of blood coagulation during therapy with high unsaturated fatty acids of omega-3 type</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4874629">US4874629</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 2, 1988</td><td class="patent-data-table-td patent-date-value">Oct 17, 1989</td><td class="patent-data-table-td ">Chang Stephen S</td><td class="patent-data-table-td ">Low temperature vacuum steam distillation combined with adsorbent treatment</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4876107">US4876107</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 4, 1988</td><td class="patent-data-table-td patent-date-value">Oct 24, 1989</td><td class="patent-data-table-td ">Unilever Patent Holdings Bv</td><td class="patent-data-table-td ">Substitute milk fat compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4911944">US4911944</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 19, 1988</td><td class="patent-data-table-td patent-date-value">Mar 27, 1990</td><td class="patent-data-table-td ">Holub Bruce J</td><td class="patent-data-table-td ">Fish meal containing unsaturated fatty acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4920098">US4920098</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 28, 1989</td><td class="patent-data-table-td patent-date-value">Apr 24, 1990</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4938984">US4938984</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 5, 1989</td><td class="patent-data-table-td patent-date-value">Jul 3, 1990</td><td class="patent-data-table-td ">Nestec S. A.</td><td class="patent-data-table-td ">Nutritive compositions containing fatty substances</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4960795">US4960795</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 28, 1988</td><td class="patent-data-table-td patent-date-value">Oct 2, 1990</td><td class="patent-data-table-td ">Norsk Hydro A.S.</td><td class="patent-data-table-td ">Polyunsaturated fatty acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4963385">US4963385</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 2, 1989</td><td class="patent-data-table-td patent-date-value">Oct 16, 1990</td><td class="patent-data-table-td ">Nabisco Brands, Inc.</td><td class="patent-data-table-td ">Chelating compounds with raffinose, trehalose or sorbitol as preservatives for fish oils</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5013569">US5013569</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 21, 1990</td><td class="patent-data-table-td patent-date-value">May 7, 1991</td><td class="patent-data-table-td ">Century Laboratories, Inc.</td><td class="patent-data-table-td ">4,7,10,13,16,19-Docosahexaenoic acid and 5,8,11,14,17-eicosapentaenoic acid or their salts, immunoglobulins, protein, carbohydrate, water; microencapsulation; concentrates</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5116871">US5116871</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 24, 1989</td><td class="patent-data-table-td patent-date-value">May 26, 1992</td><td class="patent-data-table-td ">Efamol Holdings Plc</td><td class="patent-data-table-td ">Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5120760">US5120760</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 25, 1990</td><td class="patent-data-table-td patent-date-value">Jun 9, 1992</td><td class="patent-data-table-td ">Efamol Holdings Plc</td><td class="patent-data-table-td ">Administering gamma-linolenic acid and stearidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5130242">US5130242</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 11, 1990</td><td class="patent-data-table-td patent-date-value">Jul 14, 1992</td><td class="patent-data-table-td ">Phycotech, Inc.</td><td class="patent-data-table-td ">Culture of fungi</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5198468">US5198468</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 19, 1991</td><td class="patent-data-table-td patent-date-value">Mar 30, 1993</td><td class="patent-data-table-td ">Efamol Holdings Plc</td><td class="patent-data-table-td ">Essential fatty acid composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5204250">US5204250</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 26, 1990</td><td class="patent-data-table-td patent-date-value">Apr 20, 1993</td><td class="patent-data-table-td ">Suntory Limited</td><td class="patent-data-table-td ">Process for production of arachidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5234702">US5234702</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 19, 1992</td><td class="patent-data-table-td patent-date-value">Aug 10, 1993</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Antioxidant system for powdered nutritional products</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5338673">US5338673</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 25, 1993</td><td class="patent-data-table-td patent-date-value">Aug 16, 1994</td><td class="patent-data-table-td ">Commissariat A L&#39;energie Atomique</td><td class="patent-data-table-td ">Process for the selective production of polyunsaturated fatty acids from a culture of microalgae of the porphyridium cruentum</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5397591">US5397591</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 4, 1991</td><td class="patent-data-table-td patent-date-value">Mar 14, 1995</td><td class="patent-data-table-td ">Martek Biosciences Corporation</td><td class="patent-data-table-td ">Infant formula and baby food containing docosahexaenoic acid obtained from dinoflagellates</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5407957">US5407957</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 13, 1990</td><td class="patent-data-table-td patent-date-value">Apr 18, 1995</td><td class="patent-data-table-td ">Martek Corporation</td><td class="patent-data-table-td ">Production of docosahexaenoic acid by dinoflagellates</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0140805B1?cl=en">EP0140805B1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 11, 1984</td><td class="patent-data-table-td patent-date-value">Jan 13, 1988</td><td class="patent-data-table-td ">Bio-Extraction</td><td class="patent-data-table-td ">Artifical milk for the nourishment of newly-born and young children</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0148303A1?cl=en">EP0148303A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 11, 1984</td><td class="patent-data-table-td patent-date-value">Jul 17, 1985</td><td class="patent-data-table-td ">von Mletzko, Armin, Dr.</td><td class="patent-data-table-td ">Dietetic composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0223960A2?cl=en">EP0223960A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 23, 1986</td><td class="patent-data-table-td patent-date-value">Jun 3, 1987</td><td class="patent-data-table-td ">Lion Corporation</td><td class="patent-data-table-td ">Process for the production of arachidonic acid-containing lipids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0231904A2?cl=en">EP0231904A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 30, 1987</td><td class="patent-data-table-td patent-date-value">Aug 12, 1987</td><td class="patent-data-table-td ">MILUPA GmbH &amp;amp; Co. KG</td><td class="patent-data-table-td ">Polyenic acid-rich fat composition and its use in the preparation of infants&#39; food</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0269351A2?cl=en">EP0269351A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 17, 1987</td><td class="patent-data-table-td patent-date-value">Jun 1, 1988</td><td class="patent-data-table-td ">Lion Corporation</td><td class="patent-data-table-td ">Method for producing fat containing gamma-linolenic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0276982A2?cl=en">EP0276982A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 26, 1988</td><td class="patent-data-table-td patent-date-value">Aug 3, 1988</td><td class="patent-data-table-td ">Suntory Limited</td><td class="patent-data-table-td ">Process for production of fatty acids having high degree of unsaturation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0296751A1?cl=en">EP0296751A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 15, 1988</td><td class="patent-data-table-td patent-date-value">Dec 28, 1988</td><td class="patent-data-table-td ">Efamol Holdings Plc</td><td class="patent-data-table-td ">Essential fatty acid compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=yOI_BAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH01132371A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNHEnwt5XU4j_b5TI17LW2JsaJxCXA">JPH01132371A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=yOI_BAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH01196255A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNFgyiNoePsYFj5IbgMetfXCYQY_eQ">JPH01196255A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=yOI_BAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH01215245A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNEN06GYl8n4LxyFN9Tr49TWjT6seQ">JPH01215245A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=yOI_BAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH01304892A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNFz927rgQtA2ceRAdhGErDHRcyAYw">JPH01304892A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=yOI_BAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DS6438007A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNGmNTeN9xNB9nBKsuEIQFRChuESHg">JPS6438007A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=yOI_BAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DS6480250A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNEfTT1Cn_tzFzIWlh_L6UlD0XJT-w">JPS6480250A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1989000606A1?cl=en">WO1989000606A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 20, 1988</td><td class="patent-data-table-td patent-date-value">Jan 26, 1989</td><td class="patent-data-table-td ">Maricultura Inc</td><td class="patent-data-table-td ">Microorganism production of omega-3 (n-3) lipids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1990004391A1?cl=en">WO1990004391A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 20, 1989</td><td class="patent-data-table-td patent-date-value">May 3, 1990</td><td class="patent-data-table-td ">Tillott J B Ltd</td><td class="patent-data-table-td ">Oral dosage forms of omega-3 polyunsaturated acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1990013656A1?cl=en">WO1990013656A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 1, 1990</td><td class="patent-data-table-td patent-date-value">Nov 15, 1990</td><td class="patent-data-table-td ">Enzytech Inc</td><td class="patent-data-table-td ">Enzymatic production of glycerides containing omega-3 fatty acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1992013086A1?cl=en">WO1992013086A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 22, 1992</td><td class="patent-data-table-td patent-date-value">Aug 6, 1992</td><td class="patent-data-table-td ">Martek Corp</td><td class="patent-data-table-td ">Arachidonic acid and methods for the production and use thereof</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Aaronson, et al., 1980, Microalgae as a Source of Chemicals and Natural Products, in Algal Biomass, Shelef, et al., eds., Elsevier, pp. 575 601.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Aaronson, et al., 1980,"<a href='http://scholar.google.com/scholar?q="Microalgae+as+a+Source+of+Chemicals+and+Natural+Products%2C"'>Microalgae as a Source of Chemicals and Natural Products,</a>" in Algal Biomass, Shelef, et al., eds., Elsevier, pp. 575-601.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ackman, R.G., 1989, "<a href='http://scholar.google.com/scholar?q="Problems+in+Fish+Oils+and+Concentrates%2C"'>Problems in Fish Oils and Concentrates,</a>" in Fats for the Future, Chap. 13, pp. 189-200, Cambie, ed.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ackman, R.G., 1989, Problems in Fish Oils and Concentrates, in Fats for the Future, Chap. 13, pp. 189 200, Cambie, ed.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Beach, et al., 1973, "<a href='http://scholar.google.com/scholar?q="Environmental+Influences+on+the+Docosahexaenoiate+Content+of+the+Triacylglycerols+and+Phosphatidylcholine+of+a+Heterotrophic%2C+Marine+Dinoflagellate%2C+Crypthecodinium+cohnii%2C"'>Environmental Influences on the Docosahexaenoiate Content of the Triacylglycerols and Phosphatidylcholine of a Heterotrophic, Marine Dinoflagellate, Crypthecodinium cohnii,</a>" Biochim. Biophys. Acta, 316:56-65.</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Beach, et al., 1973, Environmental Influences on the Docosahexaenoiate Content of the Triacylglycerols and Phosphatidylcholine of a Heterotrophic, Marine Dinoflagellate, Crypthecodinium cohnii, Biochim. Biophys. Acta, 316:56 65.</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bitman, et al., 1983, "<a href='http://scholar.google.com/scholar?q="Comparison+of+the+Lipid+Composition+of+Breast+Milk+from+Mothers+of+Term+and+Preterm+Infants%2C"'>Comparison of the Lipid Composition of Breast Milk from Mothers of Term and Preterm Infants,</a>" Amer. J. Clin. Nutr., 38:300-312.</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Bitman, et al., 1983, Comparison of the Lipid Composition of Breast Milk from Mothers of Term and Preterm Infants, Amer. J. Clin. Nutr., 38:300 312.</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bourre, et al., 1990, "<a href='http://scholar.google.com/scholar?q="Desaturase+in+Brain+and+Liver+During+Development+and+Aging%2C"'>Desaturase in Brain and Liver During Development and Aging,</a>" Lipids, 25:354-356.</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Bourre, et al., 1990, Desaturase in Brain and Liver During Development and Aging, Lipids, 25:354 356.</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bracco, et al., 1978, "<a href='http://scholar.google.com/scholar?q="Human+Milk+Lipids+and+Problems+Related+To+Their+Replacement%2C"'>Human Milk Lipids and Problems Related To Their Replacement,</a>" extract from Annales Nestle, No. 40, 55-81.</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Bracco, et al., 1978, Human Milk Lipids and Problems Related To Their Replacement, extract from Annales Nestle , No. 40, 55 81.</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Carlson, 1987, "<a href='http://scholar.google.com/scholar?q="Effect+of+Fish+Oil+Supplementation+on+the+n-3+Fatty+Acid+Content+of+Red+Blood+Cell+Membranes+in+Preterm+Infants%2C"'>Effect of Fish Oil Supplementation on the n-3 Fatty Acid Content of Red Blood Cell Membranes in Preterm Infants,</a>" Pediatri, Res., 21:507-510.</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Carlson, 1987, Effect of Fish Oil Supplementation on the n 3 Fatty Acid Content of Red Blood Cell Membranes in Preterm Infants, Pediatri, Res., 21:507 510.</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Carlson, et al., 1990, "<a href='http://scholar.google.com/scholar?q="Growth+and+Development+of+Very+Low-Birthweight+Infants+in+Relation+to+n-3+and+n-6+Essential+Fatty+Acid+Status%2C"'>Growth and Development of Very Low-Birthweight Infants in Relation to n-3 and n-6 Essential Fatty Acid Status,</a>" Inform, 1:192-196 (Essential Fatty Acids and Eicosanoids--Invited Papers from the Third International Congress, American Oil Chemists' Society, Champaign, Ill.</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Carlson, et al., 1990, Growth and Development of Very Low Birthweight Infants in Relation to n 3 and n 6 Essential Fatty Acid Status, Inform, 1:192 196 (Essential Fatty Acids and Eicosanoids Invited Papers from the Third International Congress, American Oil Chemists Society, Champaign, Ill.</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Carlson, et al., 1992, Essential Fatty Acids and Eicosenoids, Sinclair, et al., eds., American Oil Chem. Society, Champaign, Illinois.</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Clandinin, et al., 1985, "<a href='http://scholar.google.com/scholar?q="Long+Chain+Fatty+Acids+in+Human+Milk%3A+Are+They+of+Benefit+to+the+Newborn%3F"'>Long Chain Fatty Acids in Human Milk: Are They of Benefit to the Newborn?</a>" in Composition and Physiological Properties of Human Milk, Proc. of the Internat'l. Workshop on the Composition of Physiological Properties of Human Milk, Kiel, Germany, Schaub, J., ed.</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Clandinin, et al., 1985, Long Chain Fatty Acids in Human Milk: Are They of Benefit to the Newborn in Composition and Physiological Properties of Human Milk, Proc. of the Internat l. Workshop on the Composition of Physiological Properties of Human Milk, Kiel, Germany, Schaub, J., ed.</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hansson, et al., 1988, "<a href='http://scholar.google.com/scholar?q="Effect+of+Culture+Conditions+on+Mycelial+Growth+and+Production+of+gamma+%28%3F%29-Linolenic+Acid+by+the+Fungus+Mortierella+ramanniana%2C"'>Effect of Culture Conditions on Mycelial Growth and Production of gamma (?)-Linolenic Acid by the Fungus Mortierella ramanniana,</a>" Appl. Microbiol. Biotechnol., 28:240-246.</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Hansson, et al., 1988, Effect of Culture Conditions on Mycelial Growth and Production of gamma ( ) Linolenic Acid by the Fungus Mortierella ramanniana, Appl. Microbiol. Biotechnol., 28:240 246.</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Harrington, et al., "<a href='http://scholar.google.com/scholar?q="The+Polyunsaturated+Fatty+Acids+of+Marine+Dinoflagellates%2C"'>The Polyunsaturated Fatty Acids of Marine Dinoflagellates,</a>" J. Protozool., 17:213-219, 1970.</td></tr><tr><td class="patent-data-table-td ">23</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Harrington, et al., The Polyunsaturated Fatty Acids of Marine Dinoflagellates, J. Protozool., 17:213 219, 1970.</td></tr><tr><td class="patent-data-table-td ">24</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Harzer, et al., 1983, "<a href='http://scholar.google.com/scholar?q="Changing+Patterns+of+Human+Milk+Lipids+in+the+Course+of+the+Lactation+and+During+the+Day%2C"'>Changing Patterns of Human Milk Lipids in the Course of the Lactation and During the Day,</a>" Am. J. Clin. Nutr., 37:612-621.</td></tr><tr><td class="patent-data-table-td ">25</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Harzer, et al., 1983, Changing Patterns of Human Milk Lipids in the Course of the Lactation and During the Day, Am. J. Clin. Nutr., 37:612 621.</td></tr><tr><td class="patent-data-table-td ">26</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Henderson, et al., "<a href='http://scholar.google.com/scholar?q="Lipid+Compostion+and+Biosynthesis+in+the+Marine+Dinoflagellate+Crypthecodinium+cohnii%2C"'>Lipid Compostion and Biosynthesis in the Marine Dinoflagellate Crypthecodinium cohnii,</a>" Phytochem., 27:1679-1683 (1988).</td></tr><tr><td class="patent-data-table-td ">27</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Henderson, et al., Lipid Compostion and Biosynthesis in the Marine Dinoflagellate Crypthecodinium cohnii, Phytochem., 27:1679 1683 (1988).</td></tr><tr><td class="patent-data-table-td ">28</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Innis, et al. "<a href='http://scholar.google.com/scholar?q="Plasma+and+Red+Blood+Cell+Fatty+Acids+of+Low-Birth-Weight+Infants+Fed+Their+Mother%27s+Expressed+Breast+Milk+or+Preterm-Infant+Formula%2C"'>Plasma and Red Blood Cell Fatty Acids of Low-Birth-Weight Infants Fed Their Mother's Expressed Breast Milk or Preterm-Infant Formula,</a>" Am. J. of Clin. Nutri., 1990, 51:994-1000.</td></tr><tr><td class="patent-data-table-td ">29</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Innis, et al. Plasma and Red Blood Cell Fatty Acids of Low Birth Weight Infants Fed Their Mother s Expressed Breast Milk or Preterm Infant Formula, Am. J. of Clin. Nutri., 1990, 51:994 1000.</td></tr><tr><td class="patent-data-table-td ">30</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kame, et al., 1984, "<a href='http://scholar.google.com/scholar?q="Use+of+Fish+Oil+Fatty+Acids+%28EPA+and+DHA%29+in+Nutrition-Supplementing+Foods+and+in+Drugs%2C"'>Use of Fish Oil Fatty Acids (EPA and DHA) in Nutrition-Supplementing Foods and in Drugs,</a>" Chem. Abst., 100:6638d.</td></tr><tr><td class="patent-data-table-td ">31</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Kame, et al., 1984, Use of Fish Oil Fatty Acids (EPA and DHA) in Nutrition Supplementing Foods and in Drugs, Chem. Abst., 100:6638d.</td></tr><tr><td class="patent-data-table-td ">32</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Kyle, 1991, Adv. Applied Biotech., 12.</td></tr><tr><td class="patent-data-table-td ">33</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Pohl, et al., 1979, "<a href='http://scholar.google.com/scholar?q="Fatty+Acids+and+Lipids+of+Marine+Algae+and+the+Control+of+Their+Biosynthesis+by+Environmental+Factors%2C"'>Fatty Acids and Lipids of Marine Algae and the Control of Their Biosynthesis by Environmental Factors,</a>" Marine Algae in Pharmaceutical Science, pp. 473-523.</td></tr><tr><td class="patent-data-table-td ">34</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Pohl, et al., 1979, Fatty Acids and Lipids of Marine Algae and the Control of Their Biosynthesis by Environmental Factors, Marine Algae in Pharmaceutical Science, pp. 473 523.</td></tr><tr><td class="patent-data-table-td ">35</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Puppione, et al., 1988, "<a href='http://scholar.google.com/scholar?q="Marine+Mammals"'>Marine Mammals</a>" Animal Models for Studying the Digestion and Transport of Dietary Fats Enriched in ω-3 Fatty Acids. Positional Analyses of Milk Fat Triacylglycerol Molecules, in Dietary ω-3 and ω-6 Fatty Acids, Galli, et al., eds., Plenum Press.</td></tr><tr><td class="patent-data-table-td ">36</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Puppione, et al., 1988, Marine Mammals Animal Models for Studying the Digestion and Transport of Dietary Fats Enriched in 3 Fatty Acids. Positional Analyses of Milk Fat Triacylglycerol Molecules, in Dietary 3 and 6 Fatty Acids, Galli, et al., eds., Plenum Press.</td></tr><tr><td class="patent-data-table-td ">37</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ratledge, 1986, "<a href='http://scholar.google.com/scholar?q="The+Potential+of+Microorganisms+for+Oil+Production--A+Review+of+Recent+Publications%2C"'>The Potential of Microorganisms for Oil Production--A Review of Recent Publications,</a>" Baldwin, et al., eds., Proc. World Conf. Emerging Technol. Fats Oils Industr., Am. Oil Chem Soc., pp. 318-330.</td></tr><tr><td class="patent-data-table-td ">38</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ratledge, 1986, The Potential of Microorganisms for Oil Production A Review of Recent Publications, Baldwin, et al., eds., Proc. World Conf. Emerging Technol. Fats Oils Industr., Am. Oil Chem Soc., pp. 318 330.</td></tr><tr><td class="patent-data-table-td ">39</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Sanders, et al., 1978, "<a href='http://scholar.google.com/scholar?q="Studies+of+Vegans%3A+The+Fatty+Acid+Composition+of+Plasma+Choline+Phosphoglycerides%2C+Erythrocytes%2C+Adipose+Tissue%2C+and+Breast+Milk%2C+and+some+Indicators+of+Susceptibility+to+Ischemic+Heart+Disease+in+Vegans+and+Omnivore+Controls%2C"'>Studies of Vegans: The Fatty Acid Composition of Plasma Choline Phosphoglycerides, Erythrocytes, Adipose Tissue, and Breast Milk, and some Indicators of Susceptibility to Ischemic Heart Disease in Vegans and Omnivore Controls,</a>" Am. J. Clin. Nutri., 31:805-813.</td></tr><tr><td class="patent-data-table-td ">40</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Sanders, et al., 1978, Studies of Vegans: The Fatty Acid Composition of Plasma Choline Phosphoglycerides, Erythrocytes, Adipose Tissue, and Breast Milk, and some Indicators of Susceptibility to Ischemic Heart Disease in Vegans and Omnivore Controls, Am. J. Clin. Nutri., 31:805 813.</td></tr><tr><td class="patent-data-table-td ">41</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Shifrin, 1984, "<a href='http://scholar.google.com/scholar?q="Oils+From+Microalgae%2C"'>Oils From Microalgae,</a>" in Biotechnology for the Oils and Fats Industry, Ratledge, et al., eds., American Oil Chemists Society, Champaign, IL, pp. 145-162.</td></tr><tr><td class="patent-data-table-td ">42</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Shifrin, 1984, Oils From Microalgae, in Biotechnology for the Oils and Fats Industry, Ratledge, et al., eds., American Oil Chemists Society, Champaign, IL, pp. 145 162.</td></tr><tr><td class="patent-data-table-td ">43</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Shifrin, et al., "<a href='http://scholar.google.com/scholar?q="Phytoplankton+Lipids%3A+Environmental+Influences+on+Production+and+Possible+Commercial+Applications%2C"'>Phytoplankton Lipids: Environmental Influences on Production and Possible Commercial Applications,</a>" in Algal Biomass, Shelef, et al., eds., Elsevier, pp. 627-645 (1980).</td></tr><tr><td class="patent-data-table-td ">44</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Shifrin, et al., Phytoplankton Lipids: Environmental Influences on Production and Possible Commercial Applications, in Algal Biomass, Shelef, et al., eds., Elsevier, pp. 627 645 (1980).</td></tr><tr><td class="patent-data-table-td ">45</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Shimizu, et al. (1988), "<a href='http://scholar.google.com/scholar?q="Production+of+C-20+Polyunsaturated+Fatty+Acids+by+Fungi%2C"'>Production of C-20 Polyunsaturated Fatty Acids by Fungi,</a>" ISF-JOCS World Conference.</td></tr><tr><td class="patent-data-table-td ">46</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Shimizu, et al. (1988), "<a href='http://scholar.google.com/scholar?q="Production+of+Eicosapentaenoic+Acid+by+Mortierella+Fungi%2C"'>Production of Eicosapentaenoic Acid by Mortierella Fungi,</a>" J. Am. Oil Chem. Soc., 65:1455.</td></tr><tr><td class="patent-data-table-td ">47</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Shimizu, et al. (1988), Production of C 20 Polyunsaturated Fatty Acids by Fungi, ISF JOCS World Conference.</td></tr><tr><td class="patent-data-table-td ">48</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Shimizu, et al. (1988), Production of Eicosapentaenoic Acid by Mortierella Fungi, J. Am. Oil Chem. Soc., 65:1455.</td></tr><tr><td class="patent-data-table-td ">49</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Shimizu, et al. (1989), "<a href='http://scholar.google.com/scholar?q="Conversion+of+Linseed+Oil+to+an+Eicosapentaenoic+Acid-Containing+Oil+by+Mortierella+alpina+1S-4+at+Low+Temperature%2C"'>Conversion of Linseed Oil to an Eicosapentaenoic Acid-Containing Oil by Mortierella alpina 1S-4 at Low Temperature,</a>" Appl. Microb. Biotechnol., 31:1(-4).</td></tr><tr><td class="patent-data-table-td ">50</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Shimizu, et al. (1989), Conversion of Linseed Oil to an Eicosapentaenoic Acid Containing Oil by Mortierella alpina 1S 4 at Low Temperature, Appl. Microb. Biotechnol., 31:1( 4).</td></tr><tr><td class="patent-data-table-td ">51</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Shinmen, et al. (1989), "<a href='http://scholar.google.com/scholar?q="Production+of+Arachidonic+Acid+by+Mortierella+fungi%2C"'>Production of Arachidonic Acid by Mortierella fungi,</a>" Appl. Microb. Biotech., 31:11-16.</td></tr><tr><td class="patent-data-table-td ">52</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Shinmen, et al. (1989), Production of Arachidonic Acid by Mortierella fungi, Appl. Microb. Biotech., 31:11 16.</td></tr><tr><td class="patent-data-table-td ">53</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Sonnenborn, et al., "<a href='http://scholar.google.com/scholar?q="Purification+and+Properties+of+the+Fatty+Acid+Synthetase+Complex+From+the+Marine+Dinoflagellate%2C+Crypthecodinium+cohnii%2C"'>Purification and Properties of the Fatty Acid Synthetase Complex From the Marine Dinoflagellate, Crypthecodinium cohnii,</a>" Biochem. Biophys. Acta, 712:523-534 (1982).</td></tr><tr><td class="patent-data-table-td ">54</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Sonnenborn, et al., Purification and Properties of the Fatty Acid Synthetase Complex From the Marine Dinoflagellate, Crypthecodinium cohnii, Biochem. Biophys. Acta, 712:523 534 (1982).</td></tr><tr><td class="patent-data-table-td ">55</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Totani, et al. (1987), "<a href='http://scholar.google.com/scholar?q="The+Filamentous+Fungus+Mortierella+alpina%2C+High+in+Arachidonic+Acid%2C"'>The Filamentous Fungus Mortierella alpina, High in Arachidonic Acid,</a>" Lipids, 22:1060.</td></tr><tr><td class="patent-data-table-td ">56</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Totani, et al. (1987), The Filamentous Fungus Mortierella alpina, High in Arachidonic Acid, Lipids, 22:1060.</td></tr><tr><td class="patent-data-table-td ">57</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Totani, et al. (1988), in "<a href='http://scholar.google.com/scholar?q="Production+of+Arachidonic+Acid+by+Mortirella+alpina%2C"'>Production of Arachidonic Acid by Mortirella alpina,</a>" ISF-JOCS World Conference.</td></tr><tr><td class="patent-data-table-td ">58</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Totani, et al. (1988), in Production of Arachidonic Acid by Mortirella alpina , ISF JOCS World Conference.</td></tr><tr><td class="patent-data-table-td ">59</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Weaver, et al., 1989, "<a href='http://scholar.google.com/scholar?q="The+Effect+of+Positional+Placement+of+EPA+in+Ingested+Triglyceride+on+EPA+Accumulation+in+Human+Platelet+and+Plasma+Phospholipids%2C"'>The Effect of Positional Placement of EPA in Ingested Triglyceride on EPA Accumulation in Human Platelet and Plasma Phospholipids,</a>" in Health Effects of Fish and Fish Oils, Clandra, ed., St. John's, Newfoundland.</td></tr><tr><td class="patent-data-table-td ">60</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Weaver, et al., 1989, The Effect of Positional Placement of EPA in Ingested Triglyceride on EPA Accumulation in Human Platelet and Plasma Phospholipids, in Health Effects of Fish and Fish Oils, Clandra, ed., St. John s, Newfoundland.</td></tr><tr><td class="patent-data-table-td ">61</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Yamada, et al. (1987), "<a href='http://scholar.google.com/scholar?q="Production+of+Arachidonic+Acid+and+Eicosapentaenoic+Acid+by+Microorganisms%2C"'>Production of Arachidonic Acid and Eicosapentaenoic Acid by Microorganisms,</a>" pp. 173-177, Proc. World Congr. Biotechnol. for Oils and Fats Industr., Applewhite, ed., Am. Oil Chem. Soc., p. 173.</td></tr><tr><td class="patent-data-table-td ">62</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Yamada, et al. (1987), Production of Arachidonic Acid and Eicosapentaenoic Acid by Microorganisms, pp. 173 177, Proc. World Congr. Biotechnol. for Oils and Fats Industr., Applewhite, ed., Am. Oil Chem. Soc., p. 173.</td></tr><tr><td class="patent-data-table-td ">63</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Yamada, et al. (1989), "<a href='http://scholar.google.com/scholar?q="Biotechnological+Processes+for+Production+of+Poly-Unsaturated+Fatty+Acids%2C"'>Biotechnological Processes for Production of Poly-Unsaturated Fatty Acids,</a>" J. Disp. Sci. &amp; Tech., 10:561-579.</td></tr><tr><td class="patent-data-table-td ">64</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Yamada, et al. (1989), Biotechnological Processes for Production of Poly Unsaturated Fatty Acids, J. Disp. Sci. &amp; Tech., 10:561 579.</td></tr><tr><td class="patent-data-table-td ">65</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Yeh, et al., 1990, "<a href='http://scholar.google.com/scholar?q="Enrichment+of+%28n-3%29+Fatty+Acids+of+Suckling+Rats+by+Maternal+Dietary+Menhaden+Oil%2C"'>Enrichment of (n-3) Fatty Acids of Suckling Rats by Maternal Dietary Menhaden Oil,</a>" J. Nutr., 120.</td></tr><tr><td class="patent-data-table-td ">66</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Yeh, et al., 1990, Enrichment of (n 3) Fatty Acids of Suckling Rats by Maternal Dietary Menhaden Oil, J. Nutr., 120.</td></tr><tr><td class="patent-data-table-td ">67</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Yongmanitchai, et al., "<a href='http://scholar.google.com/scholar?q="Omega-3+Fatty+Acids%3A+Alternative+Sources+of+Production%2C"'>Omega-3 Fatty Acids: Alternative Sources of Production,</a>" Process Biochem., 24:117-125 (1989).</td></tr><tr><td class="patent-data-table-td ">68</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Yongmanitchai, et al., Omega 3 Fatty Acids: Alternative Sources of Production, Process Biochem., 24:117 125 (1989).</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5625062">US5625062</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 29, 1996</td><td class="patent-data-table-td patent-date-value">Apr 29, 1997</td><td class="patent-data-table-td ">Minnesota Mining And Manufacturing Company</td><td class="patent-data-table-td ">Method of making soluble squaraine dyes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5767156">US5767156</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 6, 1994</td><td class="patent-data-table-td patent-date-value">Jun 16, 1998</td><td class="patent-data-table-td ">Peptide Technology Limited</td><td class="patent-data-table-td ">Polyunsaturated fatty acids and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5882703">US5882703</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 10, 1996</td><td class="patent-data-table-td patent-date-value">Mar 16, 1999</td><td class="patent-data-table-td ">Omegatech, Inc.</td><td class="patent-data-table-td ">Product containing Mortierella sect. schmuckeri lipids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5968809">US5968809</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 11, 1997</td><td class="patent-data-table-td patent-date-value">Oct 19, 1999</td><td class="patent-data-table-td ">Abbot Laboratories</td><td class="patent-data-table-td ">Methods and compositions for synthesis of long chain poly-unsaturated fatty acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5972664">US5972664</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 11, 1997</td><td class="patent-data-table-td patent-date-value">Oct 26, 1999</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Methods and compositions for synthesis of long chain poly-unsaturated fatty acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6051754">US6051754</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 24, 1997</td><td class="patent-data-table-td patent-date-value">Apr 18, 2000</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Nucleic acid construct including a nucleotide sequence encoding a polypeptide which desaturates a fatty acid at carbon 5 from the carboxyl end and operably associated with regulatory sequences for gene expression in plants</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6075183">US6075183</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 11, 1997</td><td class="patent-data-table-td patent-date-value">Jun 13, 2000</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Nucleic acid construct for production of fatty acids and a desaturase in edible plant tissues and/or plant parts such as leaves, roots, fruits and seeds</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6080787">US6080787</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 3, 1997</td><td class="patent-data-table-td patent-date-value">Jun 27, 2000</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Methods for reducing the incidence of necrotizing enterocolitis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6136574">US6136574</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 29, 1999</td><td class="patent-data-table-td patent-date-value">Oct 24, 2000</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Methods and compositions for synthesis of long chain polyunsaturated fatty acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6245365">US6245365</a></td><td class="patent-data-table-td patent-date-value">Mar 15, 1999</td><td class="patent-data-table-td patent-date-value">Jun 12, 2001</td><td class="patent-data-table-td ">Omega Tech Inc.</td><td class="patent-data-table-td ">Arachidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6306908">US6306908</a></td><td class="patent-data-table-td patent-date-value">May 12, 2000</td><td class="patent-data-table-td patent-date-value">Oct 23, 2001</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Proteins, carbohydrates and lipids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6319698">US6319698</a></td><td class="patent-data-table-td patent-date-value">Jan 10, 2000</td><td class="patent-data-table-td patent-date-value">Nov 20, 2001</td><td class="patent-data-table-td ">Omega Tech, Inc.</td><td class="patent-data-table-td ">Method for producing arachidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6410288">US6410288</a></td><td class="patent-data-table-td patent-date-value">Jul 29, 1999</td><td class="patent-data-table-td patent-date-value">Jun 25, 2002</td><td class="patent-data-table-td ">Calgene, Inc.</td><td class="patent-data-table-td ">Methods and compositions for synthesis of long chain poly-unsaturated fatty acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6495599">US6495599</a></td><td class="patent-data-table-td patent-date-value">Mar 30, 2001</td><td class="patent-data-table-td patent-date-value">Dec 17, 2002</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Nutrients, nervous system development</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6541049">US6541049</a></td><td class="patent-data-table-td patent-date-value">Feb 19, 2001</td><td class="patent-data-table-td patent-date-value">Apr 1, 2003</td><td class="patent-data-table-td ">Martek Biosciences Boulder Corporation</td><td class="patent-data-table-td ">Method for production of arachidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6589767">US6589767</a></td><td class="patent-data-table-td patent-date-value">Aug 19, 1999</td><td class="patent-data-table-td patent-date-value">Jul 8, 2003</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Methods and compositions for synthesis of long chain polyunsaturated fatty acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6664405">US6664405</a></td><td class="patent-data-table-td patent-date-value">Nov 28, 2001</td><td class="patent-data-table-td patent-date-value">Dec 16, 2003</td><td class="patent-data-table-td ">Lipozen, Inc.</td><td class="patent-data-table-td ">Method for isolating high-purified unsaturated fatty acids using crystallization</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6749849">US6749849</a></td><td class="patent-data-table-td patent-date-value">Oct 5, 2001</td><td class="patent-data-table-td patent-date-value">Jun 15, 2004</td><td class="patent-data-table-td ">Martek Biosciences Corporation</td><td class="patent-data-table-td ">Method for producing arachidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6812009">US6812009</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 26, 2002</td><td class="patent-data-table-td patent-date-value">Nov 2, 2004</td><td class="patent-data-table-td ">Martek Biosciences Corporation</td><td class="patent-data-table-td ">Particulate material containing phospholipids with docosahexaenoic acid; for use as aquaculture feed</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6977166">US6977166</a></td><td class="patent-data-table-td patent-date-value">Jul 13, 2000</td><td class="patent-data-table-td patent-date-value">Dec 20, 2005</td><td class="patent-data-table-td ">The University Of Hull</td><td class="patent-data-table-td ">Method of producing an oil including docosahexaenoic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7112609">US7112609</a></td><td class="patent-data-table-td patent-date-value">Jun 10, 2003</td><td class="patent-data-table-td patent-date-value">Sep 26, 2006</td><td class="patent-data-table-td ">Drugtech Corporation</td><td class="patent-data-table-td ">Nutritional supplements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7195791">US7195791</a></td><td class="patent-data-table-td patent-date-value">Mar 4, 2004</td><td class="patent-data-table-td patent-date-value">Mar 27, 2007</td><td class="patent-data-table-td ">Martek Biosciences Corporation</td><td class="patent-data-table-td ">Method for production of archidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7531347">US7531347</a></td><td class="patent-data-table-td patent-date-value">Apr 10, 1998</td><td class="patent-data-table-td patent-date-value">May 12, 2009</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Methods and compositions for synthesis of long chain polyunsaturated fatty acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7601523">US7601523</a></td><td class="patent-data-table-td patent-date-value">Jul 24, 2007</td><td class="patent-data-table-td patent-date-value">Oct 13, 2009</td><td class="patent-data-table-td ">Martek Biosciences Corporation</td><td class="patent-data-table-td ">Method for production of arachidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7666657">US7666657</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2006</td><td class="patent-data-table-td patent-date-value">Feb 23, 2010</td><td class="patent-data-table-td ">Martek Biosciences, Inc.</td><td class="patent-data-table-td ">Method for production of arachidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7674609">US7674609</a></td><td class="patent-data-table-td patent-date-value">Feb 4, 2002</td><td class="patent-data-table-td patent-date-value">Mar 9, 2010</td><td class="patent-data-table-td ">The University Of Hull</td><td class="patent-data-table-td ">Propagating crypthecodinium in nutrient broths comprising glucose, acetic and propionic acids; increasing production of lipids and docosahexaenoic acid obtained from culture; bioreactors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7704542">US7704542</a></td><td class="patent-data-table-td patent-date-value">Sep 12, 2002</td><td class="patent-data-table-td patent-date-value">Apr 27, 2010</td><td class="patent-data-table-td ">Xanodyne Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Vitamin/mineral compositions with DHA</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7736885">US7736885</a></td><td class="patent-data-table-td patent-date-value">Jul 24, 2007</td><td class="patent-data-table-td patent-date-value">Jun 15, 2010</td><td class="patent-data-table-td ">Martek Biosciences, Inc.</td><td class="patent-data-table-td ">Method for production of arachidonic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7745694">US7745694</a></td><td class="patent-data-table-td patent-date-value">Apr 10, 1998</td><td class="patent-data-table-td patent-date-value">Jun 29, 2010</td><td class="patent-data-table-td ">Monsanto Technology Llc</td><td class="patent-data-table-td ">Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7829126">US7829126</a></td><td class="patent-data-table-td patent-date-value">Oct 20, 2006</td><td class="patent-data-table-td patent-date-value">Nov 9, 2010</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Infant formulas containing docosahexaenoic acid and lutein</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7851199">US7851199</a></td><td class="patent-data-table-td patent-date-value">Mar 20, 2006</td><td class="patent-data-table-td patent-date-value">Dec 14, 2010</td><td class="patent-data-table-td ">Microbia, Inc.</td><td class="patent-data-table-td ">Production of carotenoids in oleaginous yeast and fungi</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7939710">US7939710</a></td><td class="patent-data-table-td patent-date-value">Apr 23, 2001</td><td class="patent-data-table-td patent-date-value">May 10, 2011</td><td class="patent-data-table-td ">Martek Biosciences Corporation</td><td class="patent-data-table-td ">Trophic conversion of obligate phototrophic algae through metabolic engineering</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8007853">US8007853</a></td><td class="patent-data-table-td patent-date-value">Apr 21, 2010</td><td class="patent-data-table-td patent-date-value">Aug 30, 2011</td><td class="patent-data-table-td ">Xanodyne Pharmaceuticals, Inc.</td><td class="patent-data-table-td ">Vitamin/mineral composition with DHA</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8008061">US8008061</a></td><td class="patent-data-table-td patent-date-value">Aug 21, 2007</td><td class="patent-data-table-td patent-date-value">Aug 30, 2011</td><td class="patent-data-table-td ">Martek Biosciences Corporation</td><td class="patent-data-table-td ">Transgenic phaeodaclylurn for use as glucose transport model</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8075934">US8075934</a></td><td class="patent-data-table-td patent-date-value">Feb 13, 2009</td><td class="patent-data-table-td patent-date-value">Dec 13, 2011</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Nutritional composition with improved digestibility</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8147894">US8147894</a></td><td class="patent-data-table-td patent-date-value">Apr 21, 2008</td><td class="patent-data-table-td patent-date-value">Apr 3, 2012</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Infant formulas; provides the additional calories, protein, vitamins and minerals needed for appropriate preterm nutrition and maintain microbiological quality throughout the shelf-life of the product</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8148559">US8148559</a></td><td class="patent-data-table-td patent-date-value">Aug 28, 2008</td><td class="patent-data-table-td patent-date-value">Apr 3, 2012</td><td class="patent-data-table-td ">Clemson University Research Foundation</td><td class="patent-data-table-td ">Supercritical fluid explosion process to aid fractionation of lipids from biomass</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8232090">US8232090</a></td><td class="patent-data-table-td patent-date-value">Jun 27, 2008</td><td class="patent-data-table-td patent-date-value">Jul 31, 2012</td><td class="patent-data-table-td ">Abl Biotechnologies Ltd.</td><td class="patent-data-table-td ">Strain of Schizochytrium limacinum useful in the production of lipids and extracellular polysaccharides and process thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8263147">US8263147</a></td><td class="patent-data-table-td patent-date-value">Mar 8, 2011</td><td class="patent-data-table-td patent-date-value">Sep 11, 2012</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Infant formulas containing docosahexaenoic acid and lutein</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8277863">US8277863</a></td><td class="patent-data-table-td patent-date-value">Jul 2, 2009</td><td class="patent-data-table-td patent-date-value">Oct 2, 2012</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8288149">US8288149</a></td><td class="patent-data-table-td patent-date-value">Oct 13, 2010</td><td class="patent-data-table-td patent-date-value">Oct 16, 2012</td><td class="patent-data-table-td ">Dsm Ip Assets B.V.</td><td class="patent-data-table-td ">Production of carotenoids in oleaginous yeast and fungi</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8343753">US8343753</a></td><td class="patent-data-table-td patent-date-value">May 6, 2009</td><td class="patent-data-table-td patent-date-value">Jan 1, 2013</td><td class="patent-data-table-td ">Wake Forest University School Of Medicine</td><td class="patent-data-table-td ">Compositions, methods, and kits for polyunsaturated fatty acids from microalgae</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8349895">US8349895</a></td><td class="patent-data-table-td patent-date-value">Apr 29, 2008</td><td class="patent-data-table-td patent-date-value">Jan 8, 2013</td><td class="patent-data-table-td ">Dsm Ip Assets B.V.</td><td class="patent-data-table-td ">Products containing highly unsaturated fatty acids for use by women during stages of preconception, pregnancy and lactation/post-partum</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8425955">US8425955</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 26, 2010</td><td class="patent-data-table-td patent-date-value">Apr 23, 2013</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Nutritional composition with prebiotic component</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8529979">US8529979</a></td><td class="patent-data-table-td patent-date-value">Jun 1, 2010</td><td class="patent-data-table-td patent-date-value">Sep 10, 2013</td><td class="patent-data-table-td ">Dsm Ip Assets B.V.</td><td class="patent-data-table-td ">Stable emulsions of oils in aqueous solutions and methods for producing same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8557320">US8557320</a></td><td class="patent-data-table-td patent-date-value">Sep 4, 2012</td><td class="patent-data-table-td patent-date-value">Oct 15, 2013</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Nutritional composition having prebiotic</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8648036">US8648036</a></td><td class="patent-data-table-td patent-date-value">Dec 29, 2010</td><td class="patent-data-table-td patent-date-value">Feb 11, 2014</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8691555">US8691555</a></td><td class="patent-data-table-td patent-date-value">Sep 28, 2007</td><td class="patent-data-table-td patent-date-value">Apr 8, 2014</td><td class="patent-data-table-td ">Dsm Ip Assests B.V.</td><td class="patent-data-table-td ">Production of carotenoids in oleaginous yeast and fungi</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8722384">US8722384</a></td><td class="patent-data-table-td patent-date-value">Mar 30, 2009</td><td class="patent-data-table-td patent-date-value">May 13, 2014</td><td class="patent-data-table-td ">Calgene Llc</td><td class="patent-data-table-td ">Methods and compositions for synthesis of long chain polyunsaturated fatty acids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8728546">US8728546</a></td><td class="patent-data-table-td patent-date-value">Mar 15, 2013</td><td class="patent-data-table-td patent-date-value">May 20, 2014</td><td class="patent-data-table-td ">Swing Aerobics Licensing, Inc.</td><td class="patent-data-table-td ">Medicament for treatment of cancer, cardiovascular diseases and inflammation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20110206741">US20110206741</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 18, 2011</td><td class="patent-data-table-td patent-date-value">Aug 25, 2011</td><td class="patent-data-table-td ">Martek Biosciences Corporation</td><td class="patent-data-table-td ">DHA Triglyceride Emulsions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20130129902">US20130129902</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 2, 2010</td><td class="patent-data-table-td patent-date-value">May 23, 2013</td><td class="patent-data-table-td ">Dsm Ip Assets B.V.</td><td class="patent-data-table-td ">Composition comprising cells and a polyunsaturated fatty acid having at least 20 carbon atoms (lc-pufa)</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/CN100526445C?cl=en">CN100526445C</a></td><td class="patent-data-table-td patent-date-value">May 12, 2004</td><td class="patent-data-table-td patent-date-value">Aug 12, 2009</td><td class="patent-data-table-td ">J-制油株式会社</td><td class="patent-data-table-td ">Antioxidant fat or oil composition containing long-chain highly unsaturated fatty acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1121115A1?cl=en">EP1121115A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by third party"> †</span></td><td class="patent-data-table-td patent-date-value">Oct 15, 1999</td><td class="patent-data-table-td patent-date-value">Aug 8, 2001</td><td class="patent-data-table-td ">Dsm N.V.</td><td class="patent-data-table-td ">Pufa supplements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1645617A1?cl=en">EP1645617A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 12, 2004</td><td class="patent-data-table-td patent-date-value">Apr 12, 2006</td><td class="patent-data-table-td ">J-Oil Mills, Inc.</td><td class="patent-data-table-td ">Antioxidant fat or oil composition containing long-chain highly unsaturated fatty acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1709961A1?cl=en">EP1709961A1</a></td><td class="patent-data-table-td patent-date-value">Sep 12, 2005</td><td class="patent-data-table-td patent-date-value">Oct 11, 2006</td><td class="patent-data-table-td ">Bristol-Myers Squibb Company</td><td class="patent-data-table-td ">Use of Docosahexaenoic Acid and/or Arachidonic Acid for preventing or treating respiratory infections in infants</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1780283A1?cl=en">EP1780283A1</a></td><td class="patent-data-table-td patent-date-value">Apr 20, 2001</td><td class="patent-data-table-td patent-date-value">May 2, 2007</td><td class="patent-data-table-td ">Martek Biosciences Corporation</td><td class="patent-data-table-td ">Trophic conversion of obligate photographic algae through metabolic engineering</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2143783A1?cl=en">EP2143783A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 12, 2004</td><td class="patent-data-table-td patent-date-value">Jan 13, 2010</td><td class="patent-data-table-td ">J-Oil Mills, Inc.</td><td class="patent-data-table-td ">Antioxidant fat or oil composition containing long-chain highly unsaturated fatty acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2283736A1?cl=en">EP2283736A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 23, 2006</td><td class="patent-data-table-td patent-date-value">Feb 16, 2011</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Infant formulas containing docosahexaenoic acid and lutein</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2295535A1?cl=en">EP2295535A1</a></td><td class="patent-data-table-td patent-date-value">Sep 11, 2009</td><td class="patent-data-table-td patent-date-value">Mar 16, 2011</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Probiotic material</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2353595A1?cl=en">EP2353595A1</a></td><td class="patent-data-table-td patent-date-value">Jan 19, 2010</td><td class="patent-data-table-td patent-date-value">Aug 10, 2011</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Nutritional compensation for western-type diet</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2371967A1?cl=en">EP2371967A1</a></td><td class="patent-data-table-td patent-date-value">Mar 20, 2006</td><td class="patent-data-table-td patent-date-value">Oct 5, 2011</td><td class="patent-data-table-td ">DSM IP Assets B.V.</td><td class="patent-data-table-td ">Production of carotenoids in oleaginous yeast and fungi</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2374362A2?cl=en">EP2374362A2</a></td><td class="patent-data-table-td patent-date-value">Mar 23, 2006</td><td class="patent-data-table-td patent-date-value">Oct 12, 2011</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2000058734A1?cl=en">WO2000058734A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 27, 2000</td><td class="patent-data-table-td patent-date-value">Oct 5, 2000</td><td class="patent-data-table-td ">Allnutt Thomas F C</td><td class="patent-data-table-td ">Specific binding assay for docosahexaenoic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2001078530A2?cl=en">WO2001078530A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 12, 2001</td><td class="patent-data-table-td patent-date-value">Oct 25, 2001</td><td class="patent-data-table-td ">Abbott Lab</td><td class="patent-data-table-td ">Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2003079810A1?cl=en">WO2003079810A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 19, 2003</td><td class="patent-data-table-td patent-date-value">Oct 2, 2003</td><td class="patent-data-table-td ">David J Kyle</td><td class="patent-data-table-td ">Microalgal feeds containing arachidonic acid and their production and use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2006130200A1?cl=en">WO2006130200A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 16, 2006</td><td class="patent-data-table-td patent-date-value">Dec 7, 2006</td><td class="patent-data-table-td ">Squibb Bristol Myers Co</td><td class="patent-data-table-td ">Methods for producing protein partial hydrolysates and infant formulas containing the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2007050521A2?cl=en">WO2007050521A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 23, 2006</td><td class="patent-data-table-td patent-date-value">May 3, 2007</td><td class="patent-data-table-td ">Abbott Lab</td><td class="patent-data-table-td ">Infant formulas containing docosahexaenoic acid and lutein</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2009153249A1?cl=en">WO2009153249A1</a></td><td class="patent-data-table-td patent-date-value">Jun 16, 2009</td><td class="patent-data-table-td patent-date-value">Dec 23, 2009</td><td class="patent-data-table-td ">Unilever Nv</td><td class="patent-data-table-td ">Fat containing edible emulsions with iron and zinc</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011090922A1?cl=en">WO2011090922A1</a></td><td class="patent-data-table-td patent-date-value">Jan 18, 2011</td><td class="patent-data-table-td patent-date-value">Jul 28, 2011</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Nutritional compensation for western-type diet</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2011150337A1?cl=en">WO2011150337A1</a></td><td class="patent-data-table-td patent-date-value">May 27, 2011</td><td class="patent-data-table-td patent-date-value">Dec 1, 2011</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Nutritional compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012074844A1?cl=en">WO2012074844A1</a></td><td class="patent-data-table-td patent-date-value">Nov 22, 2011</td><td class="patent-data-table-td patent-date-value">Jun 7, 2012</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Staged infant feeding regimen to promote healthy development and growth</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012091921A1?cl=en">WO2012091921A1</a></td><td class="patent-data-table-td patent-date-value">Dec 14, 2011</td><td class="patent-data-table-td patent-date-value">Jul 5, 2012</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Use of nutritional compositions including lactoferrin in stimulating immune cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012091945A1?cl=en">WO2012091945A1</a></td><td class="patent-data-table-td patent-date-value">Dec 15, 2011</td><td class="patent-data-table-td patent-date-value">Jul 5, 2012</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012091946A2?cl=en">WO2012091946A2</a></td><td class="patent-data-table-td patent-date-value">Dec 15, 2011</td><td class="patent-data-table-td patent-date-value">Jul 5, 2012</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Method for inhibiting pathogens using a nutritional composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012094098A1?cl=en">WO2012094098A1</a></td><td class="patent-data-table-td patent-date-value">Dec 9, 2011</td><td class="patent-data-table-td patent-date-value">Jul 12, 2012</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Composition comprising heat labile milk proteins and process for preparing same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012145126A1?cl=en">WO2012145126A1</a></td><td class="patent-data-table-td patent-date-value">Mar 26, 2012</td><td class="patent-data-table-td patent-date-value">Oct 26, 2012</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Fortified milk-based nutritional compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013055438A1?cl=en">WO2013055438A1</a></td><td class="patent-data-table-td patent-date-value">Aug 15, 2012</td><td class="patent-data-table-td patent-date-value">Apr 18, 2013</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013055439A1?cl=en">WO2013055439A1</a></td><td class="patent-data-table-td patent-date-value">Aug 15, 2012</td><td class="patent-data-table-td patent-date-value">Apr 18, 2013</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Nutritional phytonutrient compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013055444A1?cl=en">WO2013055444A1</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2012</td><td class="patent-data-table-td patent-date-value">Apr 18, 2013</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Composition and method of phytonutrients for metabolic programming effects</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013055463A1?cl=en">WO2013055463A1</a></td><td class="patent-data-table-td patent-date-value">Sep 6, 2012</td><td class="patent-data-table-td patent-date-value">Apr 18, 2013</td><td class="patent-data-table-td ">Mead Johnson Nutrition Company</td><td class="patent-data-table-td ">Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013142403A1?cl=en">WO2013142403A1</a></td><td class="patent-data-table-td patent-date-value">Mar 18, 2013</td><td class="patent-data-table-td patent-date-value">Sep 26, 2013</td><td class="patent-data-table-td ">Mjn U.S. Holdings Llc</td><td class="patent-data-table-td ">Probiotic derived non-viable material for infection prevention and treatment</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014022051A1?cl=en">WO2014022051A1</a></td><td class="patent-data-table-td patent-date-value">Jul 2, 2013</td><td class="patent-data-table-td patent-date-value">Feb 6, 2014</td><td class="patent-data-table-td ">Mjn U.S. Holdings Llc</td><td class="patent-data-table-td ">Nutritional creamer composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014035582A1?cl=en">WO2014035582A1</a></td><td class="patent-data-table-td patent-date-value">Jul 30, 2013</td><td class="patent-data-table-td patent-date-value">Mar 6, 2014</td><td class="patent-data-table-td ">Mjn U.S. Holdings Llc</td><td class="patent-data-table-td ">Formula fortifier</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014092861A1?cl=en">WO2014092861A1</a></td><td class="patent-data-table-td patent-date-value">Oct 18, 2013</td><td class="patent-data-table-td patent-date-value">Jun 19, 2014</td><td class="patent-data-table-td ">Mjn U.S. Holdings Llc</td><td class="patent-data-table-td ">Nutritional composition for promoting satiety</td></tr></table><div class="patent-section-footer">* Cited by examiner, † Cited by third party</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S547000">514/547</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S560000">514/560</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A23C0009200000">A23C9/20</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A23C0011020000">A23C11/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61P0003000000">A61P3/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A23D0009007000">A23D9/007</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12P0007640000">C12P7/64</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A23L0001290000">A23L1/29</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A23C0009152000">A23C9/152</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A23L0001300000">A23L1/30</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031200000">A61K31/20</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031230000">A61K31/23</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A23V2002/00">A23V2002/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/23">A61K31/23</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A23L1/296">A23L1/296</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A23L1/3008">A23L1/3008</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=yOI_BAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/20">A61K31/20</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A23L1/29F</span>, <span class="nested-value">A23L1/30C2</span>, <span class="nested-value">A61K31/23</span>, <span class="nested-value">A61K31/20</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Dec 30, 2011</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">MARTEK BIOSCIENCES CORPORATION, MARYLAND</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE OF NAME;ASSIGNOR:MARTEK CORPORATION;REEL/FRAME:027464/0952</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19920410</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">MARTEK CORPORATION, MARYLAND</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19910123</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KYLE, DAVID JOHN;REEL/FRAME:027461/0504</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Mar 16, 2010</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 16-21 AND 24-29 ARE CANCELLED. NEW CLAIMS 32-41 ARE ADDED AND DETERMINED TO BE PATENTABLE. CLAIMS 1-15, 22-23 AND 30-31 WERE NOT REEXAMINED.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 17, 2008</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20080414</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Mar 3, 2008</td><td class="patent-data-table-td ">REMI</td><td class="patent-data-table-td ">Maintenance fee reminder mailed</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 27, 2008</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 27, 2004</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 26, 2000</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U2_wGSIGrcgBTw5A6DIkMPVPVO0UA\u0026id=yOI_BAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U3uYmXv7x1vkbOeXYvgfSwjksTEkQ\u0026id=yOI_BAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U2O0UTc6lxcx8DqhU20lKiEXmtdqA","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Blending_docosahexaenoic_acid_containing.pdf?id=yOI_BAABERAJ\u0026output=pdf\u0026sig=ACfU3U3xPzk7lDTlq9RF7sSr0HZ95_ADdw"},"sample_url":"http://www.google.com/patents/reader?id=yOI_BAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>